{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:48:34Z","timestamp":1768484914166,"version":"3.49.0"},"reference-count":231,"publisher":"e-Century Publishing Corporation","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Exp Urol"],"DOI":"10.62347\/qcpv6064","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T22:59:02Z","timestamp":1745967542000},"page":"92-117","source":"Crossref","is-referenced-by-count":3,"title":["Dual role of autophagy in bone metastasis: mechanistic insights and therapeutic targeting"],"prefix":"10.62347","volume":"13","author":[{"given":"Xinyi","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fpls.2020.00164","article-title":"Autophagy: an intracellular degradation pathway regulating plant survival and stress response","volume":"11","author":"Su","year":"2020","unstructured":"Su T, Li X, Yang M, Shao Q, Zhao Y, Ma C and Wang P. Autophagy: an intracellular degradation pathway regulating plant survival and stress response. Front Plant Sci 2020; 11: 164.","journal-title":"Front Plant Sci"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1007\/s00018-015-2034-8","article-title":"Autophagy signal transduction by ATG proteins: from hierarchies to networks","volume":"72","author":"Wesselborg","year":"2015","unstructured":"Wesselborg S and Stork B. Autophagy signal transduction by ATG proteins: from hierarchies to networks. Cell Mol Life Sci 2015; 72: 4721-4757.","journal-title":"Cell Mol Life Sci"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"101170","DOI":"10.1016\/j.drup.2024.101170","article-title":"Autophagy in cancer development, immune evasion, and drug resistance","volume":"78","author":"Niu","year":"2025","unstructured":"Niu X, You Q, Hou K, Tian Y, Wei P, Zhu Y, Gao B, Ashrafizadeh M, Aref AR, Kalbasi A, Cañadas I, Sethi G, Tergaonkar V, Wang L, Lin Y, Kang D and Klionsky DJ. Autophagy in cancer development, immune evasion, and drug resistance. Drug Resist Updat 2025; 78: 101170.","journal-title":"Drug Resist Updat"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"188592","DOI":"10.1016\/j.bbcan.2021.188592","article-title":"The role of autophagy in pancreatic cancer progression","volume":"1876","author":"Wang","year":"2021","unstructured":"Wang Y, Qin C, Yang G, Zhao B and Wang W. The role of autophagy in pancreatic cancer progression. Biochim Biophys Acta Rev Cancer 2021; 1876: 188592.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.gendis.2023.04.015","article-title":"Autophagy-related lncRNAs in tumor progression and drug resistance: a double-edged sword","volume":"11","author":"Zhang","year":"2023","unstructured":"Zhang Y, Tang J, Wang C, Zhang Q, Zeng A and Song L. Autophagy-related lncRNAs in tumor progression and drug resistance: a double-edged sword. Genes Dis 2023; 11: 367-381.","journal-title":"Genes Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nrclinonc.2011.198","article-title":"Bone cancer in 2011: prevention and treatment of bone metastases","volume":"9","author":"Coleman","year":"2011","unstructured":"Coleman RE. Bone cancer in 2011: prevention and treatment of bone metastases. Nat Rev Clin Oncol 2011; 9: 76-78.","journal-title":"Nat Rev Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"11542","DOI":"10.1002\/cam4.5577","article-title":"Autophagy: a challengeable paradox in cancer treatment","volume":"12","author":"Ahmadi-Dehlaghi","year":"2023","unstructured":"Ahmadi-Dehlaghi F, Mohammadi P, Valipour E, Pournaghi P, Kiani S and Mansouri K. Autophagy: a challengeable paradox in cancer treatment. Cancer Med 2023; 12: 11542-11569.","journal-title":"Cancer Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00774-022-01382-y","article-title":"Management of cancer pain due to bone metastasis","volume":"41","author":"Takei","year":"2023","unstructured":"Takei D and Tagami K. Management of cancer pain due to bone metastasis. J Bone Miner Metab 2023; 41: 327-336.","journal-title":"J Bone Miner Metab"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1188\/09.CJON.701-710","article-title":"Bone metastases from advanced cancers: clinical implications and treatment options","volume":"13","author":"Fitch","year":"2009","unstructured":"Fitch M, Maxwell C, Ryan C, Löthman H, Drudge-Coates L and Costa L. Bone metastases from advanced cancers: clinical implications and treatment options. Clin J Oncol Nurs 2009; 13: 701-710.","journal-title":"Clin J Oncol Nurs"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.2174\/1871520621666201202090128","article-title":"Profiling of autophagy-associated microRNAs in the osteosarcoma cell line of U2OS","volume":"21","author":"Mutlu","year":"2021","unstructured":"Mutlu H, Mutlu S and Bostancıklıoğlu M. Profiling of autophagy-associated microRNAs in the osteosarcoma cell line of U2OS. Anticancer Agents Med Chem 2021; 21: 1732-1737.","journal-title":"Anticancer Agents Med Chem"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00590-014-1468-2","article-title":"State-of-the-art approach for bone sarcomas","volume":"25","author":"Mavrogenis","year":"2015","unstructured":"Mavrogenis AF, Angelini A, Vottis C, Palmerini E, Rimondi E, Rossi G, Papagelopoulos PJ and Ruggieri P. State-of-the-art approach for bone sarcomas. Eur J Orthop Surg Traumatol 2015; 25: 5-15.","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"17901","DOI":"10.18632\/aging.203196","article-title":"Chloroquine suppresses proliferation and invasion and induces apoptosis of osteosarcoma cells associated with inhibition of phosphorylation of STAT3","volume":"13","author":"Chen","year":"2021","unstructured":"Chen C, Zhang H, Yu Y, Huang Q, Wang W, Niu J, Lou J, Ren T, Huang Y and Guo W. Chloroquine suppresses proliferation and invasion and induces apoptosis of osteosarcoma cells associated with inhibition of phosphorylation of STAT3. Aging (Albany NY) 2021; 13: 17901-17913.","journal-title":"Aging (Albany NY)"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Kiany S, Huang G and Kleinerman ES. Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis. Oncoimmunology 2017; 6: e1333214.","DOI":"10.1080\/2162402X.2017.1333214"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/cncr.22574","article-title":"Jude Children’s Research Hospital’s experience","volume":"109","author":"Weiss","year":"2007","unstructured":"Weiss A, Khoury JD, Hoffer FA, Wu J, Billups CA, Heck RK, Quintana J, Poe D, Rao BN and Daw NC. Telangiectatic osteosarcoma: the St. Jude Children’s Research Hospital’s experience. Cancer 2007; 109: 1627-1637.","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1309\/UC6KQHLD9LV2KENN","article-title":"Osteosarcoma: anatomic and histologic variants","volume":"125","author":"Klein","year":"2006","unstructured":"Klein MJ and Siegal GP. Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol 2006; 125: 555-581.","journal-title":"Am J Clin Pathol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41571-021-00519-8","article-title":"Advancing therapy for osteosarcoma","volume":"18","author":"Gill","year":"2021","unstructured":"Gill J and Gorlick R. Advancing therapy for osteosarcoma. Nat Rev Clin Oncol 2021; 18: 609-624.","journal-title":"Nat Rev Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Thebault E, Piperno-Neumann S, Tran D, Pacquement H, Marec-Berard P, Lervat C, Castex MP, Cleirec M, Bompas E, Vannier JP, Plantaz D, Saumet L, Verite C, Collard O, Pluchart C, Briandet C, Monard L, Brugieres L, Le Deley MC and Gaspar N. Successive osteosarcoma relapses after the first line O2006\/sarcome-09 trial: what can we learn for further phase-II trials? Cancers (Basel) 2021; 13: 1683.","DOI":"10.3390\/cancers13071683"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejca.2018.11.027","article-title":"Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American osteosarcoma study) cohort","volume":"109","author":"Smeland","year":"2019","unstructured":"Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, Capra M, Dhooge C, Eriksson M, Flanagan AM, Friedel G, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kühne T, Kager L, von Kalle T, Kabickova E, Lang S, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Mayer-Steinacker R, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Timmermann B, Sydes MR and Marina N. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American osteosarcoma study) cohort. Eur J Cancer 2019; 109: 36-50.","journal-title":"Eur J Cancer"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3892\/ol.2013.1154","article-title":"Effect of autophagy inhibition on chemotherapy-induced apoptosis in A549 lung cancer cells","volume":"5","author":"Liu","year":"2013","unstructured":"Liu F, Liu D, Yang Y and Zhao S. Effect of autophagy inhibition on chemotherapy-induced apoptosis in A549 lung cancer cells. Oncol Lett 2013; 5: 1261-1265.","journal-title":"Oncol Lett"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3892\/ol.2016.4644","article-title":"Ambra1 in autophagy and apoptosis: implications for cell survival and chemotherapy resistance","volume":"12","author":"Sun","year":"2016","unstructured":"Sun WL. Ambra1 in autophagy and apoptosis: implications for cell survival and chemotherapy resistance. Oncol Lett 2016; 12: 367-374.","journal-title":"Oncol Lett"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1089\/ars.2008.2270","article-title":"Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment","volume":"11","author":"MB","year":"2009","unstructured":"Azad MB, Chen Y and Gibson SB. Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment. Antioxid Redox Signal 2009; 11: 777-790.","journal-title":"Antioxid Redox Signal"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1556\/OH.2011.29269","article-title":"Role of autophagy in the pathogenesis of liver diseases","volume":"152","author":"Werling","year":"2011","unstructured":"Werling K. Role of autophagy in the pathogenesis of liver diseases. Orv Hetil 2011; 152: 1955-1961.","journal-title":"Orv Hetil"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/ncb2082","article-title":"Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation","volume":"12","author":"Gao","year":"2010","unstructured":"Gao C, Cao W, Bao L, Zuo W, Xie G, Cai T, Fu W, Zhang J, Wu W, Zhang X and Chen YG. Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation. Nat Cell Biol 2010; 12: 781-790.","journal-title":"Nat Cell Biol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41580-022-00529-z","article-title":"The emerging mechanisms and functions of microautophagy","volume":"24","author":"Wang","year":"2023","unstructured":"Wang L, Klionsky DJ and Shen HM. The emerging mechanisms and functions of microautophagy. Nat Rev Mol Cell Biol 2023; 24: 186-203.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1272\/jnms.JNMS.2024_91-102","article-title":"Molecular mechanisms of macroautophagy, microautophagy, and chaperone-mediated autophagy","volume":"91","author":"Yamamoto","year":"2024","unstructured":"Yamamoto H and Matsui T. Molecular mechanisms of macroautophagy, microautophagy, and chaperone-mediated autophagy. J Nippon Med Sch 2024; 91: 2-9.","journal-title":"J Nippon Med Sch"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Zhang G, Xiang M, Gu L, Zhou J, Zhang B, Tian W and Deng D. The essential role of TTC28 in maintaining chromosomal stability via HSPA8 chaperone-mediated autophagy. Proc Natl Acad Sci U S A 2024; 121: e2409447121.","DOI":"10.1073\/pnas.2409447121"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.3390\/cells10051258","article-title":"The autophagy machinery in human-parasitic protists; diverse functions for universally conserved proteins","volume":"10","author":"Sakamoto","year":"2021","unstructured":"Sakamoto H, Nakada-Tsukui K and Besteiro S. The autophagy machinery in human-parasitic protists; diverse functions for universally conserved proteins. Cells 2021; 10: 1528.","journal-title":"Cells"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jmb.2017.01.002","article-title":"Autophagosome maturation and fusion","volume":"429","author":"Reggiori","year":"2017","unstructured":"Reggiori F and Ungermann C. Autophagosome maturation and fusion. J Mol Biol 2017; 429: 486-496.","journal-title":"J Mol Biol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.devcel.2016.06.015","article-title":"The intrinsically disordered protein Atg13 mediates supramolecular assembly of autophagy initiation complexes","volume":"38","author":"Yamamoto","year":"2016","unstructured":"Yamamoto H, Fujioka Y, Suzuki SW, Noshiro D, Suzuki H, Kondo-Kakuta C, Kimura Y, Hirano H, Ando T, Noda NN and Ohsumi Y. The intrinsically disordered protein Atg13 mediates supramolecular assembly of autophagy initiation complexes. Dev Cell 2016; 38: 86-99.","journal-title":"Dev Cell"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1038\/ncomms10338","article-title":"The Atg1-kinase complex tethers Atg9-vesicles to initiate autophagy","volume":"7","author":"Rao","year":"2016","unstructured":"Rao Y, Perna MG, Hofmann B, Beier V and Wollert T. The Atg1-kinase complex tethers Atg9-vesicles to initiate autophagy. Nat Commun 2016; 7: 10338.","journal-title":"Nat Commun"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"20469","DOI":"10.1038\/s41598-021-99837-1","article-title":"Impaired placental mitophagy and oxidative stress are associated with dysregulated BNIP3 in preeclampsia","volume":"11","author":"Zhou","year":"2021","unstructured":"Zhou X, Zhao X, Zhou W, Qi H, Zhang H, Han TL and Baker P. Impaired placental mitophagy and oxidative stress are associated with dysregulated BNIP3 in preeclampsia. Sci Rep 2021; 11: 20469.","journal-title":"Sci Rep"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.3892\/mmr.2015.3322","article-title":"Curcumin inhibits autophagy and apoptosis in hypoxia\/reoxygenation-induced myocytes","volume":"11","author":"Huang","year":"2015","unstructured":"Huang Z, Ye B, Dai Z, Wu X, Lu Z, Shan P and Huang W. Curcumin inhibits autophagy and apoptosis in hypoxia\/reoxygenation-induced myocytes. Mol Med Rep 2015; 11: 4678-4684.","journal-title":"Mol Med Rep"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1534\/genetics.107.086199","article-title":"The ATG12-conjugating enzyme ATG10 Is essential for autophagic vesicle formation in Arabidopsis thaliana","volume":"178","author":"AR","year":"2008","unstructured":"Phillips AR, Suttangkakul A and Vierstra RD. The ATG12-conjugating enzyme ATG10 Is essential for autophagic vesicle formation in Arabidopsis thaliana. Genetics 2008; 178: 1339-1353.","journal-title":"Genetics"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1107\/S0909049507054799","article-title":"Crystallization of the Atg12-Atg5 conjugate bound to Atg16 by the free-interface diffusion method","volume":"15","author":"Noda","year":"2008","unstructured":"Noda NN, Fujioka Y, Ohsumi Y and Inagaki F. Crystallization of the Atg12-Atg5 conjugate bound to Atg16 by the free-interface diffusion method. J Synchrotron Radiat 2008; 15: 266-268.","journal-title":"J Synchrotron Radiat"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4161\/auto.3270","article-title":"Stimulation of ATG12-ATG5 conjugation by ribonucleic acid","volume":"3","author":"Shao","year":"2007","unstructured":"Shao Y, Gao Z, Feldman T and Jiang X. Stimulation of ATG12-ATG5 conjugation by ribonucleic acid. Autophagy 2007; 3: 10-16.","journal-title":"Autophagy"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"424","DOI":"10.4161\/auto.22931","article-title":"Dissecting the role of the Atg12-Atg5-Atg16 complex during autophagosome formation","volume":"9","author":"Walczak","year":"2013","unstructured":"Walczak M and Martens S. Dissecting the role of the Atg12-Atg5-Atg16 complex during autophagosome formation. Autophagy 2013; 9: 424-425.","journal-title":"Autophagy"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.4161\/auto.7.12.18025","article-title":"Atg16L2, a novel isoform of mammalian Atg16L that is not essential for canonical autophagy despite forming an Atg12-5-16L2 complex","volume":"7","author":"Ishibashi","year":"2011","unstructured":"Ishibashi K, Fujita N, Kanno E, Omori H, Yoshimori T, Itoh T and Fukuda M. Atg16L2, a novel isoform of mammalian Atg16L that is not essential for canonical autophagy despite forming an Atg12-5-16L2 complex. Autophagy 2011; 7: 1500-1513.","journal-title":"Autophagy"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.4161\/auto.28980","article-title":"Scaffolding the expansion of autophagosomes","volume":"10","author":"Kaufmann","year":"2014","unstructured":"Kaufmann A and Wollert T. Scaffolding the expansion of autophagosomes. Autophagy 2014; 10: 1343-1345.","journal-title":"Autophagy"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1080\/15548627.2021.1874132","article-title":"ATG7 is dispensable for LC3-PE conjugation in thioglycolate-elicited mouse peritoneal macrophages","volume":"17","author":"Vuji&#x107","year":"2021","unstructured":"Vujić N, Bradić I, Goeritzer M, Kuentzel KB, Rainer S, Kratky D and Radović B. ATG7 is dispensable for LC3-PE conjugation in thioglycolate-elicited mouse peritoneal macrophages. Autophagy 2021; 17: 3402-3407.","journal-title":"Autophagy"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bbrc.2005.10.211","article-title":"Molecular cloning and characterization of rat LC3A and LC3B--two novel markers of autophagosome","volume":"339","author":"Wu","year":"2006","unstructured":"Wu J, Dang Y, Su W, Liu C, Ma H, Shan Y, Pei Y, Wan B, Guo J and Yu L. Molecular cloning and characterization of rat LC3A and LC3B--two novel markers of autophagosome. Biochem Biophys Res Commun 2006; 339: 437-442.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.3390\/nu5062231","article-title":"The role of mechanistic target of rapamycin (mTOR) complexes signaling in the immune responses","volume":"5","author":"Soliman","year":"2013","unstructured":"Soliman GA. The role of mechanistic target of rapamycin (mTOR) complexes signaling in the immune responses. Nutrients 2013; 5: 2231-2257.","journal-title":"Nutrients"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Lamming DW. Inhibition of the mechanistic target of rapamycin (mTOR)-rapamycin and beyond. Cold Spring Harb Perspect Med 2016; 6: a025924.","DOI":"10.1101\/cshperspect.a025924"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1134\/S0006297914020023","article-title":"Kinase mTOR: regulation and role in maintenance of cellular homeostasis, tumor development, and aging","volume":"79","author":"Parkhitko","year":"2014","unstructured":"Parkhitko AA, Favorova OO, Khabibullin DI, Anisimov VN and Henske EP. Kinase mTOR: regulation and role in maintenance of cellular homeostasis, tumor development, and aging. Biochemistry (Mosc) 2014; 79: 88-101.","journal-title":"Biochemistry (Mosc)"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/ph16071004","article-title":"Exploring the mTOR signalling pathway and its inhibitory scope in cancer","volume":"16","author":"Mir","year":"2023","unstructured":"Mir SA, Dar A, Alshehri SA, Wahab S, Hamid L, Almoyad MAA, Ali T and Bader GN. Exploring the mTOR signalling pathway and its inhibitory scope in cancer. Pharmaceuticals (Basel) 2023; 16: 1004.","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1128\/MCB.05430-11","article-title":"Relieving autophagy and 4EBP1 from rapamycin resistance","volume":"31","author":"Nyfeler","year":"2011","unstructured":"Nyfeler B, Bergman P, Triantafellow E, Wilson CJ, Zhu Y, Radetich B, Finan PM, Klionsky DJ and Murphy LO. Relieving autophagy and 4EBP1 from rapamycin resistance. Mol Cell Biol 2011; 31: 2867-2876.","journal-title":"Mol Cell Biol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1128\/MCB.00079-13","article-title":"Role of membrane association and Atg14-dependent phosphorylation in beclin-1-mediated autophagy","volume":"33","author":"Fogel","year":"2013","unstructured":"Fogel AI, Dlouhy BJ, Wang C, Ryu SW, Neutzner A, Hasson SA, Sideris DP, Abeliovich H and Youle RJ. Role of membrane association and Atg14-dependent phosphorylation in beclin-1-mediated autophagy. Mol Cell Biol 2013; 33: 3675-3688.","journal-title":"Mol Cell Biol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ceb.2010.01.001","article-title":"The Beclin 1 interactome","volume":"22","author":"He","year":"2010","unstructured":"He C and Levine B. The Beclin 1 interactome. Curr Opin Cell Biol 2010; 22: 140-149.","journal-title":"Curr Opin Cell Biol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.biochi.2020.04.025","article-title":"The beclin 1 interactome: modification and roles in the pathology of autophagy-related disorders","volume":"175","author":"Kaur","year":"2020","unstructured":"Kaur S and Changotra H. The beclin 1 interactome: modification and roles in the pathology of autophagy-related disorders. Biochimie 2020; 175: 34-49.","journal-title":"Biochimie"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1080\/15548627.2019.1569947","article-title":"MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy","volume":"15","author":"Huang","year":"2019","unstructured":"Huang T, Wan X, Alvarez AA, James CD, Song X, Yang Y, Sastry N, Nakano I, Sulman EP, Hu B and Cheng SY. MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy. Autophagy 2019; 15: 1100-1111.","journal-title":"Autophagy"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01652176.2024.2419585","article-title":"Beclin-1 and LC3B expression in canine mast cell tumours: an immuno-ultrastructural and immunohistochemical study of autophagy","volume":"44","author":"GP","year":"2024","unstructured":"Vicente GP, Della Salda L and Strefezzi RF. Beclin-1 and LC3B expression in canine mast cell tumours: an immuno-ultrastructural and immunohistochemical study of autophagy. Vet Q 2024; 44: 1-15.","journal-title":"Vet Q"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12253-017-0310-7","article-title":"High LC3\/beclin expression correlates with poor survival in glioma: a definitive role for autophagy as evidenced by in vitro autophagic flux","volume":"25","author":"Cj","year":"2019","unstructured":"Cj P, Hv E, Vijayakurup V, R Menon G, Nair S and Gopala S. High LC3\/beclin expression correlates with poor survival in glioma: a definitive role for autophagy as evidenced by in vitro autophagic flux. Pathol Oncol Res 2019; 25: 137-148.","journal-title":"Pathol Oncol Res"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/cdd.2008.131","article-title":"Control of autophagy by oncogenes and tumor suppressor genes","volume":"16","author":"Maiuri","year":"2009","unstructured":"Maiuri MC, Tasdemir E, Criollo A, Morselli E, Vicencio JM, Carnuccio R and Kroemer G. Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ 2009; 16: 87-93.","journal-title":"Cell Death Differ"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1182\/blood-2011-11-366062","article-title":"Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies","volume":"119","author":"Xu-Monette","year":"2012","unstructured":"Xu-Monette ZY, Medeiros LJ, Li Y, Orlowski RZ, Andreeff M, Bueso-Ramos CE, Greiner TC, McDonnell TJ and Young KH. Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies. Blood 2012; 119: 3668-3683.","journal-title":"Blood"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"607149","DOI":"10.3389\/fonc.2020.607149","article-title":"Mutant p53 as a regulator and target of autophagy","volume":"10","author":"Shi","year":"2021","unstructured":"Shi Y, Norberg E and Vakifahmetoglu-Norberg H. Mutant p53 as a regulator and target of autophagy. Front Oncol 2021; 10: 607149.","journal-title":"Front Oncol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"810","DOI":"10.4161\/auto.6486","article-title":"A dual role of p53 in the control of autophagy","volume":"4","author":"Tasdemir","year":"2008","unstructured":"Tasdemir E, Chiara Maiuri M, Morselli E, Criollo A, D’Amelio M, Djavaheri-Mergny M, Cecconi F, Tavernarakis N and Kroemer G. A dual role of p53 in the control of autophagy. Autophagy 2008; 4: 810-814.","journal-title":"Autophagy"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"White E. Autophagy and p53. Cold Spring Harb Perspect Med 2016; 6: a026120.","DOI":"10.1101\/cshperspect.a026120"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4161\/auto.1.1.1542","article-title":"The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function","volume":"1","author":"Furuya","year":"2005","unstructured":"Furuya N, Yu J, Byfield M, Pattingre S and Levine B. The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy 2005; 1: 46-52.","journal-title":"Autophagy"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1172\/JCI20039","article-title":"Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene","volume":"112","author":"Qu","year":"2003","unstructured":"Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, Cattoretti G and Levine B. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003; 112: 1809-1820.","journal-title":"J Clin Invest"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.prp.2011.05.002","article-title":"Mutational and expressional analyses of ATG5, an autophagy-related gene, in gastrointestinal cancers","volume":"207","author":"CH","year":"2011","unstructured":"An CH, Kim MS, Yoo NJ, Park SW and Lee SH. Mutational and expressional analyses of ATG5, an autophagy-related gene, in gastrointestinal cancers. Pathol Res Pract 2011; 207: 433-437.","journal-title":"Pathol Res Pract"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Zhang KK, Burns CM, Skinner ME, Lombard DB, Miller RA and Endicott SJ. PTEN is both an activator and a substrate of chaperone-mediated autophagy. J Cell Biol 2023; 222: e202208150.","DOI":"10.1083\/jcb.202208150"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1080\/10428190500144813","article-title":"PTEN and p27 expression in mature T-cell and NK-cell neoplasms","volume":"46","author":"AH","year":"2005","unstructured":"Uner AH, Sağlam A, Han U, Hayran M, Sungur A and Ruacan S. PTEN and p27 expression in mature T-cell and NK-cell neoplasms. Leuk Lymphoma 2005; 46: 1463-1470.","journal-title":"Leuk Lymphoma"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/s41388-017-0046-6","article-title":"Dual role of autophagy in hallmarks of cancer","volume":"37","author":"Singh","year":"2018","unstructured":"Singh SS, Vats S, Chia AY, Tan TZ, Deng S, Ong MS, Arfuso F, Yap CT, Goh BC, Sethi G, Huang RY, Shen HM, Manjithaya R and Kumar AP. Dual role of autophagy in hallmarks of cancer. Oncogene 2018; 37: 1142-1158.","journal-title":"Oncogene"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1080\/15548627.2019.1634445","article-title":"The double-edged sword of MTOR in autophagy deficiency induced-liver injury and tumorigenesis","volume":"15","author":"Yang","year":"2019","unstructured":"Yang H, Ni HM and Ding WX. The double-edged sword of MTOR in autophagy deficiency induced-liver injury and tumorigenesis. Autophagy 2019; 15: 1671-1673.","journal-title":"Autophagy"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Muthusami S, Ramachandran IK, Babu KN, Krishnamoorthy S, Guruswamy A, Queimado L, Chaudhuri G and Ramachandran I. Role of inflammation in the development of colorectal cancer. Endocr Metab Immune Disord Drug Targets 2021; 21: 77-90.","DOI":"10.2174\/1871530320666200909092908"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ygcen.2014.09.006","article-title":"Endoplasmic reticulum stress is involved in the connection between inflammation and autophagy in type 2 diabetes","volume":"210","author":"Liu","year":"2015","unstructured":"Liu H, Cao MM, Wang Y, Li LC, Zhu LB, Xie GY and Li YB. Endoplasmic reticulum stress is involved in the connection between inflammation and autophagy in type 2 diabetes. Gen Comp Endocrinol 2015; 210: 124-129.","journal-title":"Gen Comp Endocrinol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ccr.2011.03.018","article-title":"The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment","volume":"19","author":"Li","year":"2011","unstructured":"Li N, Grivennikov SI and Karin M. The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell 2011; 19: 429-431.","journal-title":"Cancer Cell"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/HEP.0000000000000821","article-title":"Early onset of pathological polyploidization and cellular senescence in hepatocytes lacking RAD51 creates a pro-fibrotic and pro-tumorigenic inflammatory microenvironment","volume":"81","author":"Bu","year":"2025","unstructured":"Bu W, Sun X, Xue X, Geng S, Yang T, Zhang J, Li Y, Feng C, Liu Q, Zhang X, Li P, Liu Z, Shi Y and Shao C. Early onset of pathological polyploidization and cellular senescence in hepatocytes lacking RAD51 creates a pro-fibrotic and pro-tumorigenic inflammatory microenvironment. Hepatology 2025; 81: 491-508.","journal-title":"Hepatology"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41577-023-00894-6","article-title":"The multifunctional protein HMGB1: 50 years of discovery","volume":"23","author":"Tang","year":"2023","unstructured":"Tang D, Kang R, Zeh HJ and Lotze MT. The multifunctional protein HMGB1: 50 years of discovery. Nat Rev Immunol 2023; 23: 824-841.","journal-title":"Nat Rev Immunol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.1038\/s41467-019-13475-w","article-title":"A truncating mutation in the autophagy gene UVRAG drives inflammation and tumorigenesis in mice","volume":"10","author":"Quach","year":"2019","unstructured":"Quach C, Song Y, Guo H, Li S, Maazi H, Fung M, Sands N, O’Connell D, Restrepo-Vassalli S, Chai B, Nemecio D, Punj V, Akbari O, Idos GE, Mumenthaler SM, Wu N, Martin SE, Hagiya A, Hicks J, Cui H and Liang C. A truncating mutation in the autophagy gene UVRAG drives inflammation and tumorigenesis in mice. Nat Commun 2019; 10: 5681.","journal-title":"Nat Commun"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.cell.2016.04.006","article-title":"Fanconi anemia proteins function in mitophagy and immunity","volume":"165","author":"R Jr","year":"2016","unstructured":"Sumpter R Jr, Sirasanagandla S, Fernández ÁF, Wei Y, Dong X, Franco L, Zou Z, Marchal C, Lee MY, Clapp DW, Hanenberg H and Levine B. Fanconi anemia proteins function in mitophagy and immunity. Cell 2016; 165: 867-881.","journal-title":"Cell"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"487","DOI":"10.5483\/BMBRep.2015.48.9.176","article-title":"Amino-terminal arginylation as a degradation signal for selective autophagy","volume":"48","author":"Cha-Molstad H","year":"2015","unstructured":"Cha-Molstad H, Kwon YT and Kim BY. Amino-terminal arginylation as a degradation signal for selective autophagy. BMB Rep 2015; 48: 487-488.","journal-title":"BMB Rep"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/15548627.2016.1278327","article-title":"Stress-induced polyubiquitination of proteasomal ubiquitin receptors targets the proteolytic complex for autophagic degradation","volume":"13","author":"Cohen-Kaplan V","year":"2017","unstructured":"Cohen-Kaplan V, Ciechanover A and Livneh I. Stress-induced polyubiquitination of proteasomal ubiquitin receptors targets the proteolytic complex for autophagic degradation. Autophagy 2017; 13: 759-760.","journal-title":"Autophagy"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Huang X, Yao J, Liu L, Chen J, Mei L, Huangfu J, Luo D, Wang X, Lin C, Chen X, Yang Y, Ouyang S, Wei F, Wang Z, Zhang S, Xiang T, Neculai D, Sun Q, Kong E, Tate EW and Yang A. S-acylation of p62 promotes p62 droplet recruitment into autophagosomes in mammalian autophagy. Mol Cell 2023; 83: 3485-3501, e11.","DOI":"10.1016\/j.molcel.2023.09.004"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1248\/bpb.b22-00131","article-title":"Oxidative stress impairs autophagy via inhibition of lysosomal transport of VAMP8","volume":"45","author":"Ohnishi","year":"2022","unstructured":"Ohnishi Y, Tsuji D and Itoh K. Oxidative stress impairs autophagy via inhibition of lysosomal transport of VAMP8. Biol Pharm Bull 2022; 45: 1609-1615.","journal-title":"Biol Pharm Bull"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00018-022-04144-1","article-title":"Autophagosome-lysosome fusion is facilitated by plectin-stabilized actin and keratin 8 during macroautophagic process","volume":"79","author":"Son","year":"2022","unstructured":"Son S, Baek A, Lee JH and Kim DE. Autophagosome-lysosome fusion is facilitated by plectin-stabilized actin and keratin 8 during macroautophagic process. Cell Mol Life Sci 2022; 79: 95.","journal-title":"Cell Mol Life Sci"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.7150\/ijbs.76134","article-title":"Autophagy-related proteins in genome stability: autophagy-dependent and independent actions","volume":"18","author":"Zhang","year":"2022","unstructured":"Zhang Y, Guo R, Wang SS, Jiang XY, Cui HY, Guo Y, Song XY, Guo QQ and Cao L. Autophagy-related proteins in genome stability: autophagy-dependent and independent actions. Int J Biol Sci 2022; 18: 5329-5344.","journal-title":"Int J Biol Sci"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Cheng SM, Shieh MC, Lin TY and Cheung CHA. The “dark side” of autophagy on the maintenance of genome stability: does it really exist during excessive activation? J Cell Physiol 2022; 237: 178-188.","DOI":"10.1002\/jcp.30555"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.1093\/nar\/gkm1059","article-title":"DNA replication stress, genome instability and aging","volume":"35","author":"Burhans","year":"2007","unstructured":"Burhans WC and Weinberger M. DNA replication stress, genome instability and aging. Nucleic Acids Res 2007; 35: 7545-7556.","journal-title":"Nucleic Acids Res"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Kawamura K, Qi F and Kobayashi J. Potential relationship between the biological effects of low-dose irradiation and mitochondrial ROS production. J Radiat Res 2018; 59: ii91-ii97.","DOI":"10.1093\/jrr\/rrx091"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.3390\/cancers14143462","article-title":"Autophagy-related gene signature highlights metabolic and immunogenic status of malignant cells in non-small cell lung cancer adenocarcinoma","volume":"14","author":"Leonardi","year":"2022","unstructured":"Leonardi L, Siberil S, Alifano M, Cremer I and Joubert PE. Autophagy-related gene signature highlights metabolic and immunogenic status of malignant cells in non-small cell lung cancer adenocarcinoma. Cancers (Basel) 2022; 14: 3462.","journal-title":"Cancers (Basel)"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.3390\/cells10113213","article-title":"Resveratrol contrasts LPA-induced ovarian cancer cell migration and platinum resistance by rescuing hedgehog-mediated autophagy","volume":"10","author":"Ferraresi","year":"2021","unstructured":"Ferraresi A, Esposito A, Girone C, Vallino L, Salwa A, Ghezzi I, Thongchot S, Vidoni C, Dhanasekaran DN and Isidoro C. Resveratrol contrasts LPA-induced ovarian cancer cell migration and platinum resistance by rescuing hedgehog-mediated autophagy. Cells 2021; 10: 3213.","journal-title":"Cells"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1370012","DOI":"10.3389\/fcell.2024.1370012","article-title":"Activating transcription factor 4: a regulator of stress response in human cancers","volume":"12","author":"Wu","year":"2024","unstructured":"Wu D and Liang J. Activating transcription factor 4: a regulator of stress response in human cancers. Front Cell Dev Biol 2024; 12: 1370012.","journal-title":"Front Cell Dev Biol"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Josset E, Burckel H, Noël G and Bischoff P. The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line. Anticancer Res 2013; 33: 1845-1851.","DOI":"10.3892\/or.2014.3590"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Lefranc F and Kiss R. Autophagy, the Trojan horse to combat glioblastomas. Neurosurg Focus 2006; 20: E7.","DOI":"10.3171\/foc.2006.20.4.4"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Vera-Ramirez L. Cell-intrinsic survival signals. The role of autophagy in metastatic dissemination and tumor cell dormancy. Semin Cancer Biol 2020; 60: 28-40.","DOI":"10.1016\/j.semcancer.2019.07.027"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.3390\/cancers14174289","article-title":"Therapeutic potential for targeting autophagy in ER+ breast cancer","volume":"14","author":"Finnegan","year":"2022","unstructured":"Finnegan RM, Elshazly AM, Schoenlein PV and Gewirtz DA. Therapeutic potential for targeting autophagy in ER+ breast cancer. Cancers (Basel) 2022; 14: 4289.","journal-title":"Cancers (Basel)"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1080\/15548627.2020.1753001","article-title":"Autophagy suppresses breast cancer metastasis by degrading NBR1","volume":"16","author":"Marsh","year":"2020","unstructured":"Marsh T and Debnath J. Autophagy suppresses breast cancer metastasis by degrading NBR1. Autophagy 2020; 16: 1164-1165.","journal-title":"Autophagy"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Fitzwalter BE, Towers CG, Sullivan KD, Andrysik Z, Hoh M, Ludwig M, O’Prey J, Ryan KM, Espinosa JM, Morgan MJ and Thorburn A. Autophagy inhibition mediates apoptosis sensitization in cancer therapy by relieving FOXO3a turnover. Dev Cell 2018; 44: 555-565, e3.","DOI":"10.1016\/j.devcel.2018.02.014"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.3390\/cancers13174310","article-title":"Bone metastatic breast cancer: advances in cell signaling and autophagy related mechanisms","volume":"13","author":"Othman","year":"2021","unstructured":"Othman A, Winogradzki M, Lee L, Tandon M, Blank A and Pratap J. Bone metastatic breast cancer: advances in cell signaling and autophagy related mechanisms. Cancers (Basel) 2021; 13: 4310.","journal-title":"Cancers (Basel)"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1158\/0008-5472.CAN-19-4021","article-title":"Soft microenvironments induce chemoresistance by increasing autophagy downstream of integrin-linked kinase","volume":"80","author":"Anla&#x15F","year":"2020","unstructured":"Anlaş AA and Nelson CM. Soft microenvironments induce chemoresistance by increasing autophagy downstream of integrin-linked kinase. Cancer Res 2020; 80: 4103-4113.","journal-title":"Cancer Res"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/cancers11071020","article-title":"The bone extracellular matrix as an ideal milieu for cancer cell metastases","volume":"11","author":"Kolb","year":"2019","unstructured":"Kolb AD and Bussard KM. The bone extracellular matrix as an ideal milieu for cancer cell metastases. Cancers (Basel) 2019; 11: 1020.","journal-title":"Cancers (Basel)"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/bcr2781","article-title":"Breast cancer metastasis to the bone: mechanisms of bone loss","volume":"12","author":"YC","year":"2010","unstructured":"Chen YC, Sosnoski DM and Mastro AM. Breast cancer metastasis to the bone: mechanisms of bone loss. Breast Cancer Res 2010; 12: 215.","journal-title":"Breast Cancer Res"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/03008207.2017.1290085","article-title":"Osteoblast-osteoclast interactions","volume":"59","author":"Chen","year":"2018","unstructured":"Chen X, Wang Z, Duan N, Zhu G, Schwarz EM and Xie C. Osteoblast-osteoclast interactions. Connect Tissue Res 2018; 59: 99-107.","journal-title":"Connect Tissue Res"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3389\/fcell.2020.00507","article-title":"Osteoclast signal transduction during bone metastasis formation","volume":"8","author":"Gy&#x151","year":"2020","unstructured":"Győri DS and Mócsai A. Osteoclast signal transduction during bone metastasis formation. Front Cell Dev Biol 2020; 8: 507.","journal-title":"Front Cell Dev Biol"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1177\/0022034518764411","article-title":"Emerging role of extracellular vesicles in bone remodeling","volume":"97","author":"Liu","year":"2018","unstructured":"Liu M, Sun Y and Zhang Q. Emerging role of extracellular vesicles in bone remodeling. J Dent Res 2018; 97: 859-868.","journal-title":"J Dent Res"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fcell.2020.00089","article-title":"The role of bone-derived exosomes in regulating skeletal metabolism and extraosseous diseases","volume":"8","author":"Lyu","year":"2020","unstructured":"Lyu H, Xiao Y, Guo Q, Huang Y and Luo X. The role of bone-derived exosomes in regulating skeletal metabolism and extraosseous diseases. Front Cell Dev Biol 2020; 8: 89.","journal-title":"Front Cell Dev Biol"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00018-022-04298-y","article-title":"Regulation of osteoclast-mediated bone resorption by microRNA","volume":"79","author":"Ji","year":"2022","unstructured":"Ji L, Li X, He S and Chen S. Regulation of osteoclast-mediated bone resorption by microRNA. Cell Mol Life Sci 2022; 79: 287.","journal-title":"Cell Mol Life Sci"},{"key":"ref97","doi-asserted-by":"publisher","unstructured":"Chen X, Tian P, Chai W, Zhang L, Qin M, Fan M, Liang N, Kim J, Wang Y, Lu WW, Wang D, Cui X and Pan H. A multisynergistic strategy for bone tumor treatment: orchestrating oxidative stress and autophagic flux inhibition by environmental-response nanoparticle. Adv Healthc Mater 2025; 14: e2402872.","DOI":"10.1002\/adhm.202402872"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"8832541","DOI":"10.1155\/2021\/8832541","article-title":"Autophagy paradox of cancer: role, regulation, and duality","volume":"2021","author":"Verma","year":"2021","unstructured":"Verma AK, Bharti PS, Rafat S, Bhatt D, Goyal Y, Pandey KK, Ranjan S, Almatroodi SA, Alsahli MA, Rahmani AH, Almatroudi A and Dev K. Autophagy paradox of cancer: role, regulation, and duality. Oxid Med Cell Longev 2021; 2021: 8832541.","journal-title":"Oxid Med Cell Longev"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3390\/ijms21020613","article-title":"Bone marrow stromal cells-induced drug resistance in multiple myeloma","volume":"21","author":"Ria","year":"2020","unstructured":"Ria R and Vacca A. Bone marrow stromal cells-induced drug resistance in multiple myeloma. Int J Mol Sci 2020; 21: 613.","journal-title":"Int J Mol Sci"},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"Zeng Y, Pan Z, Yuan J, Song Y, Feng Z, Chen Z, Ye Z, Li Y, Bao Y, Ran Z, Li X, Ye H, Zhang K, Liu X and He Y. Inhibiting osteolytic breast cancer bone metastasis by bone-targeted nanoagent via remodeling the bone tumor microenvironment combined with NIR-II photothermal therapy. Small 2023; 19: e2301003.","DOI":"10.1002\/smll.202301003"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.4161\/cc.26298","article-title":"Autophagy modulates cell migration and β1 integrin membrane recycling","volume":"12","author":"Tuloup-Minguez V","year":"2013","unstructured":"Tuloup-Minguez V, Hamaï A, Greffard A, Nicolas V, Codogno P and Botti J. Autophagy modulates cell migration and β1 integrin membrane recycling. Cell Cycle 2013; 12: 3317-3328.","journal-title":"Cell Cycle"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"1472574","DOI":"10.3389\/fcell.2024.1472574","article-title":"The dual role of autophagy in suppressing and promoting hepatocellular carcinoma","volume":"12","author":"Mohammed","year":"2024","unstructured":"Mohammed WH, Sulaiman GM, Abomughaid MM, Klionsky DJ and Abu-Alghayth MH. The dual role of autophagy in suppressing and promoting hepatocellular carcinoma. Front Cell Dev Biol 2024; 12: 1472574.","journal-title":"Front Cell Dev Biol"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","unstructured":"Henry DH, Costa L, Goldwasser F, Hirsh V, Hungria V, Prausova J, Scagliotti GV, Sleeboom H, Spencer A, Vadhan-Raj S, von Moos R, Willenbacher W, Woll PJ, Wang J, Jiang Q, Jun S, Dansey R and Yeh H. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol 2011; 29: 1125-1132.","journal-title":"J Clin Oncol"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00520-013-2022-1","article-title":"Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors","volume":"22","author":"Henry","year":"2014","unstructured":"Henry D, Vadhan-Raj S, Hirsh V, von Moos R, Hungria V, Costa L, Woll PJ, Scagliotti G, Smith G, Feng A, Jun S, Dansey R and Yeh H. Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors. Support Care Cancer 2014; 22: 679-687.","journal-title":"Support Care Cancer"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","unstructured":"Fizazi K, Carducci M, Smith M, Damião R, Brown J, Karsh L, Milecki P, Shore N, Rader M, Wang H, Jiang Q, Tadros S, Dansey R and Goessl C. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet 2011; 377: 813-822.","journal-title":"Lancet"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1097\/JTO.0b013e31826aec2b","article-title":"Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study","volume":"7","author":"GV","year":"2012","unstructured":"Scagliotti GV, Hirsh V, Siena S, Henry DH, Woll PJ, Manegold C, Solal-Celigny P, Rodriguez G, Krzakowski M, Mehta ND, Lipton L, García-Sáenz JA, Pereira JR, Prabhash K, Ciuleanu TE, Kanarev V, Wang H, Balakumaran A and Jacobs I. Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study. J Thorac Oncol 2012; 7: 1823-1829.","journal-title":"J Thorac Oncol"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature14336","article-title":"Therapy-induced tumour secretomes promote resistance and tumour progression","volume":"520","author":"AC","year":"2015","unstructured":"Obenauf AC, Zou Y, Ji AL, Vanharanta S, Shu W, Shi H, Kong X, Bosenberg MC, Wiesner T, Rosen N, Lo RS and Massagué J. Therapy-induced tumour secretomes promote resistance and tumour progression. Nature 2015; 520: 368-372.","journal-title":"Nature"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.lungcan.2010.04.003","article-title":"Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases","volume":"71","author":"Sun","year":"2011","unstructured":"Sun JM, Ahn JS, Lee S, Kim JA, Lee J, Park YH, Park HC, Ahn MJ, Ahn YC and Park K. Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases. Lung Cancer 2011; 71: 89-93.","journal-title":"Lung Cancer"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1200\/JCO.2012.45.0494","article-title":"Cabozantinib in patients with advanced prostate cancer: results of a phase ii randomized discontinuation trial","volume":"31","author":"DC","year":"2013","unstructured":"Smith DC, Smith MR, Sweeney C, Elfiky AA, Logothetis C, Corn PG, Vogelzang NJ, Small EJ, Harzstark AL, Gordon MS, Vaishampayan UN, Haas NB, Spira AI, Lara PN Jr, Lin CC, Srinivas S, Sella A, Schöffski P, Scheffold C, Weitzman AL and Hussain M. Cabozantinib in patients with advanced prostate cancer: results of a phase ii randomized discontinuation trial. J Clin Oncol 2013; 31: 412-419.","journal-title":"J Clin Oncol"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1200\/JCO.2015.65.5597","article-title":"Phase III study of cabozantinib in previously treated metastatic castration-resistant prostate cancer: COMET-1","volume":"34","author":"Smith","year":"2016","unstructured":"Smith M, De Bono J, Sternberg C, Le Moulec S, Oudard S, De Giorgi U, Krainer M, Bergman A, Hoelzer W, De Wit R, Bögemann M, Saad F, Cruciani G, Thiery-Vuillemin A, Feyerabend S, Miller K, Houédé N, Hussain S, Lam E, Polikoff J, Stenzl A, Mainwaring P, Ramies D, Hessel C, Weitzman A and Fizazi K. Phase III study of cabozantinib in previously treated metastatic castration-resistant prostate cancer: COMET-1. J Clin Oncol 2016; 34: 3005-3013.","journal-title":"J Clin Oncol"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1158\/1078-0432.CCR-15-0235","article-title":"Integrating murine and clinical trials with cabozantinib to understand roles of MET and VEGFR2 as targets for growth inhibition of prostate cancer","volume":"22","author":"Varkaris","year":"2016","unstructured":"Varkaris A, Corn PG, Parikh NU, Efstathiou E, Song JH, Lee YC, Aparicio A, Hoang AG, Gaur S, Thorpe L, Maity SN, Bar Eli M, Czerniak BA, Shao Y, Alauddin M, Lin SH, Logothetis CJ and Gallick GE. Integrating murine and clinical trials with cabozantinib to understand roles of MET and VEGFR2 as targets for growth inhibition of prostate cancer. Clin Cancer Res 2016; 22: 107-121.","journal-title":"Clin Cancer Res"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00223-017-0353-5","article-title":"Bone-targeted therapies in cancer-induced bone disease","volume":"102","author":"Sousa","year":"2018","unstructured":"Sousa S and Clézardin P. Bone-targeted therapies in cancer-induced bone disease. Calcif Tissue Int 2018; 102: 227-250.","journal-title":"Calcif Tissue Int"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13058-017-0885-7","article-title":"Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer","volume":"19","author":"AJ","year":"2017","unstructured":"Browne AJ, Kubasch ML, Göbel A, Hadji P, Chen D, Rauner M, Stölzel F, Hofbauer LC and Rachner TD. Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer. Breast Cancer Res 2017; 19: 92.","journal-title":"Breast Cancer Res"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1182\/blood-2009-08-237404","article-title":"Dysregulation of bone remodeling by imatinib mesylate","volume":"115","author":"Vandyke","year":"2010","unstructured":"Vandyke K, Fitter S, Dewar AL, Hughes TP and Zannettino AC. Dysregulation of bone remodeling by imatinib mesylate. Blood 2010; 115: 766-774.","journal-title":"Blood"},{"key":"ref115","doi-asserted-by":"publisher","unstructured":"Gobin B, Moriceau G, Ory B, Charrier C, Brion R, Blanchard F, Redini F and Heymann D. Imatinib mesylate exerts anti-proliferative effects on osteosarcoma cells and inhibits the tumour growth in immunocompetent murine models. PLoS One 2014; 9: e90795.","DOI":"10.1371\/journal.pone.0090795"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.annonc.2020.07.019","article-title":"Bone health in cancer: ESMO clinical practice guidelines","volume":"31","author":"Coleman","year":"2020","unstructured":"Coleman R, Hadji P, Body JJ, Santini D, Chow E, Terpos E, Oudard S, Bruland Ø, Flamen P, Kurth A, Van Poznak C, Aapro M and Jordan K; ESMO Guidelines Committee. Bone health in cancer: ESMO clinical practice guidelines. Ann Oncol 2020; 31: 1650-1663.","journal-title":"Ann Oncol"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"RE","year":"2020","unstructured":"Coleman RE, Croucher PI, Padhani AR, Clézardin P, Chow E, Fallon M, Guise T, Colangeli S, Capanna R and Costa L. Bone metastases. Nat Rev Dis Primers 2020; 6: 83.","journal-title":"Nat Rev Dis Primers"},{"key":"ref118","unstructured":"Han MW, Lee JC, Choi JY, Kim GC, Chang HW, Nam HY, Kim SW and Kim SY. Autophagy inhibition can overcome radioresistance in breast cancer cells through suppression of TAK1 activation. Anticancer Res 2014; 34: 1449-1455."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.bcp.2019.03.015","article-title":"Late autophagy inhibitor chloroquine improves efficacy of the histone deacetylase inhibitor SAHA and temozolomide in gliomas","volume":"163","author":"Gon&#xE7","year":"2019","unstructured":"Gonçalves RM, Agnes JP, Delgobo M, de Souza PO, Thomé MP, Heimfarth L, Lenz G, Moreira JCF and Zanotto-Filho A. Late autophagy inhibitor chloroquine improves efficacy of the histone deacetylase inhibitor SAHA and temozolomide in gliomas. Biochem Pharmacol 2019; 163: 440-450.","journal-title":"Biochem Pharmacol"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12967-022-03462-z","article-title":"Inhibition of autophagy by chloroquine prevents resistance to PI3K\/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models","volume":"20","author":"Cocco","year":"2022","unstructured":"Cocco S, Leone A, Roca MS, Lombardi R, Piezzo M, Caputo R, Ciardiello C, Costantini S, Bruzzese F, Sisalli MJ, Budillon A and De Laurentiis M. Inhibition of autophagy by chloroquine prevents resistance to PI3K\/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models. J Transl Med 2022; 20: 290.","journal-title":"J Transl Med"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1530\/ERC-13-0183","article-title":"LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy","volume":"21","author":"Nagelkerke","year":"2014","unstructured":"Nagelkerke A, Sieuwerts AM, Bussink J, Sweep FC, Look MP, Foekens JA, Martens JW and Span PN. LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy. Endocr Relat Cancer 2014; 21: 101-112.","journal-title":"Endocr Relat Cancer"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1007\/s13277-015-3800-9","article-title":"Protective autophagy promotes the resistance of HER2-positive breast cancer cells to lapatinib","volume":"37","author":"Chen","year":"2016","unstructured":"Chen S, Zhu X, Qiao H, Ye M, Lai X, Yu S, Ding L, Wen A and Zhang J. Protective autophagy promotes the resistance of HER2-positive breast cancer cells to lapatinib. Tumour Biol 2016; 37: 2321-2331.","journal-title":"Tumour Biol"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13568-020-01044-0","article-title":"The role of autophagy in the cytotoxicity induced by trastuzumab emtansine (T-DM1) in HER2-positive breast cancer cells","volume":"10","author":"Liu","year":"2020","unstructured":"Liu P, Fan J, Wang Z, Zai W, Song P, Li Y and Ju D. The role of autophagy in the cytotoxicity induced by trastuzumab emtansine (T-DM1) in HER2-positive breast cancer cells. AMB Express 2020; 10: 107.","journal-title":"AMB Express"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41392-019-0069-2","article-title":"Targeted therapeutic options and future perspectives for HER2-positive breast cancer","volume":"4","author":"Wang","year":"2019","unstructured":"Wang J and Xu B. Targeted therapeutic options and future perspectives for HER2-positive breast cancer. Signal Transduct Target Ther 2019; 4: 34.","journal-title":"Signal Transduct Target Ther"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3892\/ol.2021.13011","article-title":"Progress on the study of the anticancer effects of artesunate","volume":"22","author":"Yang","year":"2021","unstructured":"Yang X, Zheng Y, Liu L, Huang J, Wang F and Zhang J. Progress on the study of the anticancer effects of artesunate. Oncol Lett 2021; 22: 750.","journal-title":"Oncol Lett"},{"key":"ref126","doi-asserted-by":"publisher","unstructured":"Guan X and Guan Y. Artemisinin induces selective and potent anticancer effects in drug resistant breast cancer cells by inducing cellular apoptosis and autophagy and G2\/M cell cycle arrest. J BUON 2020; 25: 1330-1336.","DOI":"10.12659\/MSM.916116"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1074\/jbc.M110.210047","article-title":"Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production","volume":"286","author":"Hamacher-Brady","year":"2011","unstructured":"Hamacher-Brady A, Stein HA, Turschner S, Toegel I, Mora R, Jennewein N, Efferth T, Eils R and Brady NR. Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production. J Biol Chem 2011; 286: 6587-6601.","journal-title":"J Biol Chem"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12951-022-01569-5","article-title":"Development of artesunate intelligent prodrug liposomes based on mitochondrial targeting strategy","volume":"20","author":"Gu","year":"2022","unstructured":"Gu L, Zhang J, Liu D, Chen J, Liu S, Peng Q, Tian Y, Du M, Zhang J, Xiao W, Shen S and Wang J. Development of artesunate intelligent prodrug liposomes based on mitochondrial targeting strategy. J Nanobiotechnology 2022; 20: 376.","journal-title":"J Nanobiotechnology"},{"key":"ref129","unstructured":"Wang M, Qiu S and Qin J. Baicalein induced apoptosis and autophagy of undifferentiated thyroid cancer cells by the ERK\/PI3K\/Akt pathway. Am J Transl Res 2019; 11: 3341-3352."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s11010-022-04597-9","article-title":"Baicalein sensitizes triple negative breast cancer MDA-MB-231 cells to doxorubicin via autophagy-mediated down-regulation of CDK1","volume":"478","author":"Hua","year":"2023","unstructured":"Hua F, Xiao YY, Qu XH, Li SS, Zhang K, Zhou C, He JL, Zhu Y, Wan YY, Jiang LP, Tou FF and Han XJ. Baicalein sensitizes triple negative breast cancer MDA-MB-231 cells to doxorubicin via autophagy-mediated down-regulation of CDK1. Mol Cell Biochem 2023; 478: 1519-1531.","journal-title":"Mol Cell Biochem"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1142\/S0192415X19500721","article-title":"Baicalein induces autophagy and apoptosis through AMPK pathway in human glioma cells","volume":"47","author":"Liu","year":"2019","unstructured":"Liu B, Ding L, Zhang L, Wang S, Wang Y, Wang B and Li L. Baicalein induces autophagy and apoptosis through AMPK pathway in human glioma cells. Am J Chin Med 2019; 47: 1405-1418.","journal-title":"Am J Chin Med"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.2147\/DDDT.S181939","article-title":"Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K\/AKT pathway in vivo and vitro","volume":"12","author":"Yan","year":"2018","unstructured":"Yan W, Ma X, Zhao X and Zhang S. Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K\/AKT pathway in vivo and vitro. Drug Des Devel Ther 2018; 12: 3961-3972.","journal-title":"Drug Des Devel Ther"},{"key":"ref133","unstructured":"Rajabi S, Irani M, Moeinifard M and Hamzeloo-Moghadam M. Britannin suppresses MCF-7 breast cancer cell growth by inducing apoptosis and inhibiting autophagy. Avicenna J Phytomed 2024; 14: 90-99."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1371002","DOI":"10.3389\/fphar.2024.1371002","article-title":"Sesquiterpene lactones as emerging biomolecules to cease cancer by targeting apoptosis","volume":"15","author":"Hsu","year":"2024","unstructured":"Hsu CY, Rajabi S, Hamzeloo-Moghadam M, Kumar A, Maresca M and Ghildiyal P. Sesquiterpene lactones as emerging biomolecules to cease cancer by targeting apoptosis. Front Pharmacol 2024; 15: 1371002.","journal-title":"Front Pharmacol"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11033-023-09131-8","article-title":"Gaillardin inhibits autophagy and induces apoptosis in MCF-7 breast cancer cells by regulating JAK\/STAT pathway","volume":"51","author":"Rajabi","year":"2024","unstructured":"Rajabi S, Tahmasvand Z, Maresca M and Hamzeloo-Moghadam M. Gaillardin inhibits autophagy and induces apoptosis in MCF-7 breast cancer cells by regulating JAK\/STAT pathway. Mol Biol Rep 2024; 51: 158.","journal-title":"Mol Biol Rep"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"558741","DOI":"10.3389\/fphar.2020.558741","article-title":"Celastrol: a review of useful strategies overcoming its limitation in anticancer application","volume":"11","author":"Shi","year":"2020","unstructured":"Shi J, Li J, Xu Z, Chen L, Luo R, Zhang C, Gao F, Zhang J and Fu C. Celastrol: a review of useful strategies overcoming its limitation in anticancer application. Front Pharmacol 2020; 11: 558741.","journal-title":"Front Pharmacol"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"114254","DOI":"10.1016\/j.ejmech.2022.114254","article-title":"Scaffold hopping of celastrol provides derivatives containing pepper ring, pyrazine and oxazole substructures as potent autophagy inducers against breast cancer cell line MCF-7","volume":"234","author":"Feng","year":"2022","unstructured":"Feng Y, Zhang B, Lv J, Zhang P, Mao Q, Lin F, Zhao J, Fu X, Yang Y, Li Z, Zhang L, Mou Y and Wang S. Scaffold hopping of celastrol provides derivatives containing pepper ring, pyrazine and oxazole substructures as potent autophagy inducers against breast cancer cell line MCF-7. Eur J Med Chem 2022; 234: 114254.","journal-title":"Eur J Med Chem"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"5532269","DOI":"10.1155\/2021\/5532269","article-title":"The synergistic effects of celastrol in combination with tamoxifen on apoptosis and autophagy in MCF-7 cells","volume":"2021","author":"Wang","year":"2021","unstructured":"Wang L, Tang L, Yao C, Liu C and Shu Y. The synergistic effects of celastrol in combination with tamoxifen on apoptosis and autophagy in MCF-7 cells. J Immunol Res 2021; 2021: 5532269.","journal-title":"J Immunol Res"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.3390\/ijms11125323","article-title":"Antiproliferative effects of cucurbitacin B in breast cancer cells: down-regulation of the c-Myc\/hTERT\/telomerase pathway and obstruction of the cell cycle","volume":"11","author":"Duangmano","year":"2010","unstructured":"Duangmano S, Dakeng S, Jiratchariyakul W, Suksamrarn A, Smith DR and Patmasiriwat P. Antiproliferative effects of cucurbitacin B in breast cancer cells: down-regulation of the c-Myc\/hTERT\/telomerase pathway and obstruction of the cell cycle. Int J Mol Sci 2010; 11: 5323-5338.","journal-title":"Int J Mol Sci"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s11418-015-0918-4","article-title":"Cucurbitacin B induces DNA damage and autophagy mediated by reactive oxygen species (ROS) in MCF-7 breast cancer cells","volume":"69","author":"Ren","year":"2015","unstructured":"Ren G, Sha T, Guo J, Li W, Lu J and Chen X. Cucurbitacin B induces DNA damage and autophagy mediated by reactive oxygen species (ROS) in MCF-7 breast cancer cells. J Nat Med 2015; 69: 522-530.","journal-title":"J Nat Med"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.canlet.2010.01.029","article-title":"Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration","volume":"294","author":"Chan","year":"2010","unstructured":"Chan KT, Meng FY, Li Q, Ho CY, Lam TS, To Y, Lee WH, Li M, Chu KH and Toh M. Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration. Cancer Lett 2010; 294: 118-124.","journal-title":"Cancer Lett"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/foods6100092","article-title":"Curcumin: a review of its effects on human health","volume":"6","author":"Hewlings","year":"2017","unstructured":"Hewlings SJ and Kalman DS. Curcumin: a review of its effects on human health. Foods 2017; 6: 92.","journal-title":"Foods"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1002\/jcb.27775","article-title":"Photodynamic treatment with anionic nanoclays containing curcumin on human triple-negative breast cancer cells: cellular and biochemical studies","volume":"120","author":"Khorsandi","year":"2019","unstructured":"Khorsandi K, Hosseinzadeh R and Shahidi FK. Photodynamic treatment with anionic nanoclays containing curcumin on human triple-negative breast cancer cells: cellular and biochemical studies. J Cell Biochem 2019; 120: 4998-5009.","journal-title":"J Cell Biochem"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"26064","DOI":"10.1038\/srep26064","article-title":"Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death","volume":"6","author":"Wang","year":"2016","unstructured":"Wang K, Zhang C, Bao J, Jia X, Liang Y, Wang X, Chen M, Su H, Li P, Wan JB and He C. Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death. Sci Rep 2016; 6: 26064.","journal-title":"Sci Rep"},{"key":"ref145","doi-asserted-by":"publisher","unstructured":"Jiang S, Chang H, Deng S and Fan D. Icariin enhances the chemosensitivity of cisplatinresistant ovarian cancer cells by suppressing autophagy via activation of the AKT\/mTOR\/ATG5 pathway. Int J Oncol 2019; 54: 1933-1942.","DOI":"10.3892\/ijo.2019.4785"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/molecules28031109","article-title":"Icaritin derivative ic2 induces cytoprotective autophagy of breast cancer cells via SCD1 inhibition","volume":"28","author":"Wang","year":"2023","unstructured":"Wang YX, Jin YY, Wang J, Zhao ZC, Xue KW, Xiong H, Che HL, Ge YJ and Wu GS. Icaritin derivative ic2 induces cytoprotective autophagy of breast cancer cells via SCD1 inhibition. Molecules 2023; 28: 1109.","journal-title":"Molecules"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s12282-019-00980-5","article-title":"Icariin induces apoptosis by suppressing autophagy in tamoxifen-resistant breast cancer cell line MCF-7\/TAM","volume":"26","author":"Cheng","year":"2019","unstructured":"Cheng X, Tan S, Duan F, Yuan Q, Li Q and Deng G. Icariin induces apoptosis by suppressing autophagy in tamoxifen-resistant breast cancer cell line MCF-7\/TAM. Breast Cancer 2019; 26: 766-775.","journal-title":"Breast Cancer"},{"key":"ref148","doi-asserted-by":"publisher","unstructured":"Wu CL, Liu JF, Liu Y, Wang YX, Fu KF, Yu XJ, Pu Q, Chen XX and Zhou LJ. Beclin1 inhibition enhances paclitaxelmediated cytotoxicity in breast cancer in vitro and in vivo. Int J Mol Med 2019; 43: 1866-1878.","DOI":"10.3892\/ijmm.2019.4089"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"114458","DOI":"10.1016\/j.biopha.2023.114458","article-title":"Autophagy in cancer resistance to paclitaxel: development of combination strategies","volume":"161","author":"&#x160","year":"2023","unstructured":"Škubník J, Svobodová Pavlíčková V, Ruml T and Rimpelová S. Autophagy in cancer resistance to paclitaxel: development of combination strategies. Biomed Pharmacother 2023; 161: 114458.","journal-title":"Biomed Pharmacother"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s13577-023-00900-y","article-title":"TIPE2 sensitizes breast cancer cells to paclitaxel by suppressing drug-induced autophagy and cancer stem cell properties","volume":"36","author":"Hu","year":"2023","unstructured":"Hu W, Zheng W, Du J, Tian Z, Zhao Y, Zhao P and Li J. TIPE2 sensitizes breast cancer cells to paclitaxel by suppressing drug-induced autophagy and cancer stem cell properties. Hum Cell 2023; 36: 1485-1500.","journal-title":"Hum Cell"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"115024","DOI":"10.1016\/j.bcp.2022.115024","article-title":"Resveratrol sensitizes breast cancer to PARP inhibitor, talazoparib through dual inhibition of AKT and autophagy flux","volume":"199","author":"Pai Bellare","year":"2022","unstructured":"Pai Bellare G and Sankar Patro B. Resveratrol sensitizes breast cancer to PARP inhibitor, talazoparib through dual inhibition of AKT and autophagy flux. Biochem Pharmacol 2022; 199: 115024.","journal-title":"Biochem Pharmacol"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ptr.7608","article-title":"Resveratrol reverses TGF-β1-mediated invasion and metastasis of breast cancer cells via the SIRT3\/AMPK\/autophagy signal axis","volume":"37","author":"Wang","year":"2023","unstructured":"Wang J, Huang P, Pan X, Xia C, Zhang H, Zhao H, Yuan Z, Liu J, Meng C and Liu F. Resveratrol reverses TGF-β1-mediated invasion and metastasis of breast cancer cells via the SIRT3\/AMPK\/autophagy signal axis. Phytother Res 2023; 37: 211-230.","journal-title":"Phytother Res"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/jcb.24997","article-title":"The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells","volume":"116","author":"Alayev","year":"2015","unstructured":"Alayev A, Berger SM, Kramer MY, Schwartz NS and Holz MK. The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells. J Cell Biochem 2015; 116: 450-457.","journal-title":"J Cell Biochem"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/jphp.13339","article-title":"Tetrandrine: a review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems","volume":"72","author":"Luan","year":"2020","unstructured":"Luan F, He X and Zeng N. Tetrandrine: a review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems. J Pharm Pharmacol 2020; 72: 1491-1512.","journal-title":"J Pharm Pharmacol"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"1534735421996822","DOI":"10.1177\/1534735421996822","article-title":"Resuming sensitivity of tamoxifen-resistant breast cancer cells to tamoxifen by tetrandrine","volume":"20","author":"Wang","year":"2021","unstructured":"Wang Y, Yue W, Lang H, Ding X, Chen X and Chen H. Resuming sensitivity of tamoxifen-resistant breast cancer cells to tamoxifen by tetrandrine. Integr Cancer Ther 2021; 20: 1534735421996822.","journal-title":"Integr Cancer Ther"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3389\/fphar.2017.00351","article-title":"Tetrandrine, an activator of autophagy, induces autophagic cell death via PKC-α inhibition and mTOR-dependent mechanisms","volume":"8","author":"Wong","year":"2017","unstructured":"Wong VKW, Zeng W, Chen J, Yao XJ, Leung ELH, Wang QQ, Chiu P, Ko BCB and Law BYK. Tetrandrine, an activator of autophagy, induces autophagic cell death via PKC-α inhibition and mTOR-dependent mechanisms. Front Pharmacol 2017; 8: 351.","journal-title":"Front Pharmacol"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s40121-021-00400-2","article-title":"Computational and experimental studies reveal that thymoquinone blocks the entry of coronaviruses into in vitro cells","volume":"10","author":"Xu","year":"2021","unstructured":"Xu H, Liu B, Xiao Z, Zhou M, Ge L, Jia F, Liu Y, Jin H, Zhu X, Gao J, Akhtar J, Xiang B, Tan K and Wang G. Computational and experimental studies reveal that thymoquinone blocks the entry of coronaviruses into in vitro cells. Infect Dis Ther 2021; 10: 483-494.","journal-title":"Infect Dis Ther"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2174\/1871520620666200807221047","article-title":"Thymoquinone inhibits proliferation and migration of MDA-MB-231 triple negative breast cancer cells by suppressing autophagy, Beclin-1 and LC3","volume":"21","author":"&#xDC","year":"2021","unstructured":"Ünal TD, Hamurcu Z, Delibaşı N, Çınar V, Güler A, Gökçe S, Nurdinov N and Ozpolat B. Thymoquinone inhibits proliferation and migration of MDA-MB-231 triple negative breast cancer cells by suppressing autophagy, Beclin-1 and LC3. Anticancer Agents Med Chem 2021; 21: 355-364.","journal-title":"Anticancer Agents Med Chem"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"18124","DOI":"10.1038\/s41598-020-75017-5","article-title":"Incorporation of docetaxel and thymoquinone in borage nanoemulsion potentiates their antineoplastic activity in breast cancer cells","volume":"10","author":"MH","year":"2020","unstructured":"Alkhatib MH, Bawadud RS and Gashlan HM. Incorporation of docetaxel and thymoquinone in borage nanoemulsion potentiates their antineoplastic activity in breast cancer cells. Sci Rep 2020; 10: 18124.","journal-title":"Sci Rep"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1743-7075-11-52","article-title":"Pharmacological potential of tocotrienols: a review","volume":"11","author":"Ahsan","year":"2014","unstructured":"Ahsan H, Ahad A, Iqbal J and Siddiqui WA. Pharmacological potential of tocotrienols: a review. Nutr Metab (Lond) 2014; 11: 52.","journal-title":"Nutr Metab (Lond)"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11010-015-2488-x","article-title":"Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy","volume":"408","author":"RV","year":"2015","unstructured":"Tiwari RV, Parajuli P and Sylvester PW. Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy. Mol Cell Biochem 2015; 408: 123-137.","journal-title":"Mol Cell Biochem"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1139\/bcb-2014-0123","article-title":"γ-Tocotrienol-induced endoplasmic reticulum stress and autophagy act concurrently to promote breast cancer cell death","volume":"93","author":"RV","year":"2015","unstructured":"Tiwari RV, Parajuli P and Sylvester PW. γ-Tocotrienol-induced endoplasmic reticulum stress and autophagy act concurrently to promote breast cancer cell death. Biochem Cell Biol 2015; 93: 306-320.","journal-title":"Biochem Cell Biol"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.3390\/molecules27113399","article-title":"Ursolic acid enhances the sensitivity of MCF-7 and MDA-MB-231 cells to epirubicin by modulating the autophagy pathway","volume":"27","author":"Wang","year":"2022","unstructured":"Wang Z, Zhang P, Jiang H, Sun B, Luo H and Jia A. Ursolic acid enhances the sensitivity of MCF-7 and MDA-MB-231 cells to epirubicin by modulating the autophagy pathway. Molecules 2022; 27: 3399.","journal-title":"Molecules"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.3892\/etm.2017.4965","article-title":"Ursolic acid inhibits breast cancer growth by inhibiting proliferation, inducing autophagy and apoptosis, and suppressing inflammatory responses via the PI3K\/AKT and NF-κB signaling pathways in vitro","volume":"14","author":"Luo","year":"2017","unstructured":"Luo J, Hu YL and Wang H. Ursolic acid inhibits breast cancer growth by inhibiting proliferation, inducing autophagy and apoptosis, and suppressing inflammatory responses via the PI3K\/AKT and NF-κB signaling pathways in vitro. Exp Ther Med 2017; 14: 3623-3631.","journal-title":"Exp Ther Med"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s10495-017-1353-7","article-title":"Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells","volume":"22","author":"Lewinska","year":"2017","unstructured":"Lewinska A, Adamczyk-Grochala J, Kwasniewicz E, Deregowska A and Wnuk M. Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells. Apoptosis 2017; 22: 800-815.","journal-title":"Apoptosis"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.juro.2014.01.006","article-title":"Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent","volume":"191","author":"Ojha","year":"2014","unstructured":"Ojha R, Singh SK, Bhattacharyya S, Dhanda RS, Rakha A, Mandal AK and Jha V. Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent. J Urol 2014; 191: 1889-1898.","journal-title":"J Urol"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"176035","DOI":"10.1016\/j.ejphar.2023.176035","article-title":"Targeted inhibition of mTOR by BML-275 induces mitochondrial-mediated apoptosis and autophagy in prostate cancer","volume":"957","author":"Li","year":"2023","unstructured":"Li W, Li D, Ma Q, Chen Y, Hu Z, Bai Y and Xie L. Targeted inhibition of mTOR by BML-275 induces mitochondrial-mediated apoptosis and autophagy in prostate cancer. Eur J Pharmacol 2023; 957: 176035.","journal-title":"Eur J Pharmacol"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12935-021-02043-2","article-title":"Metformin exerts anti-AR-negative prostate cancer activity via AMPK\/autophagy signaling pathway","volume":"21","author":"Chen","year":"2021","unstructured":"Chen C, Wang H, Geng X, Zhang D, Zhu Z, Zhang G and Hou J. Metformin exerts anti-AR-negative prostate cancer activity via AMPK\/autophagy signaling pathway. Cancer Cell Int 2021; 21: 404.","journal-title":"Cancer Cell Int"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1080\/15548627.2020.1820787","article-title":"An inverted CAV1 (caveolin 1) topology defines novel autophagy-dependent exosome secretion from prostate cancer cells","volume":"17","author":"Ariotti","year":"2021","unstructured":"Ariotti N, Wu Y, Okano S, Gambin Y, Follett J, Rae J, Ferguson C, Teasdale RD, Alexandrov K, Meunier FA, Hill MM and Parton RG. An inverted CAV1 (caveolin 1) topology defines novel autophagy-dependent exosome secretion from prostate cancer cells. Autophagy 2021; 17: 2200-2216.","journal-title":"Autophagy"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.3390\/cancers14122861","article-title":"IFI35 promotes renal cancer progression by inhibiting pSTAT1\/pSTAT6-dependent autophagy","volume":"14","author":"Chai","year":"2022","unstructured":"Chai D, Shi SY, Sobhani N, Ding J, Zhang Z, Jiang N, Wang G, Li M, Li H, Zheng J and Bai J. IFI35 promotes renal cancer progression by inhibiting pSTAT1\/pSTAT6-dependent autophagy. Cancers (Basel) 2022; 14: 2861.","journal-title":"Cancers (Basel)"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ebiom.2018.07.034","article-title":"Overexpression of ulk1 represents a potential diagnostic marker for clear cell renal carcinoma and the antitumor effects of SBI-0206965","volume":"34","author":"Lu","year":"2018","unstructured":"Lu J, Zhu L, Zheng LP, Cui Q, Zhu HH, Zhao H, Shen ZJ, Dong HY, Chen SS, Wu WZ and Tan JM. Overexpression of ulk1 represents a potential diagnostic marker for clear cell renal carcinoma and the antitumor effects of SBI-0206965. EBioMedicine 2018; 34: 85-93.","journal-title":"EBioMedicine"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1021\/acs.jmedchem.1c02113","article-title":"Discovery and structure-based optimization of novel Atg4B inhibitors for the treatment of castration-resistant prostate cancer","volume":"65","author":"Kudo","year":"2022","unstructured":"Kudo Y, Endo S, Fujita M, Ota A, Kamatari YO, Tanaka Y, Ishikawa T, Ikeda H, Okada T, Toyooka N, Fujimoto N, Matsunaga T and Ikari A. Discovery and structure-based optimization of novel Atg4B inhibitors for the treatment of castration-resistant prostate cancer. J Med Chem 2022; 65: 4878-4892.","journal-title":"J Med Chem"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"110135","DOI":"10.1016\/j.abb.2024.110135","article-title":"Docosahexaenoic acid enhances the treatment efficacy for castration-resistant prostate cancer by inhibiting autophagy through Atg4B inhibition","volume":"760","author":"Kudo","year":"2024","unstructured":"Kudo Y, Nakamura K, Tsuzuki H, Hirota K, Kawai M, Takaya D, Fukuzawa K, Honma T, Yoshino Y, Nakamura M, Shiota M, Fujimoto N, Ikari A and Endo S. Docosahexaenoic acid enhances the treatment efficacy for castration-resistant prostate cancer by inhibiting autophagy through Atg4B inhibition. Arch Biochem Biophys 2024; 760: 110135.","journal-title":"Arch Biochem Biophys"},{"key":"ref174","doi-asserted-by":"publisher","unstructured":"Jiang H, Sun J, Xu Q, Liu Y, Wei J, Young CY, Yuan H and Lou H. Marchantin M: a novel inhibitor of proteasome induces autophagic cell death in prostate cancer cells. Cell Death Dis 2013; 4: e761.","DOI":"10.1038\/cddis.2013.285"},{"key":"ref175","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/jcm8040442","article-title":"NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses castration-resistant prostate cancer growth via regulation of apoptosis and autophagy","volume":"8","author":"Etani","year":"2019","unstructured":"Etani T, Naiki T, Naiki-Ito A, Suzuki T, Iida K, Nozaki S, Kato H, Nagayasu Y, Suzuki S, Kawai N, Yasui T and Takahashi S. NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses castration-resistant prostate cancer growth via regulation of apoptosis and autophagy. J Clin Med 2019; 8: 442.","journal-title":"J Clin Med"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41419-018-1006-y","article-title":"Novel dihydroartemisinin derivative DHA-37 induces autophagic cell death through upregulation of HMGB1 in A549 cells","volume":"9","author":"Liu","year":"2018","unstructured":"Liu X, Wu J, Fan M, Shen C, Dai W, Bao Y, Liu JH and Yu BY. Novel dihydroartemisinin derivative DHA-37 induces autophagic cell death through upregulation of HMGB1 in A549 cells. Cell Death Dis 2018; 9: 1048.","journal-title":"Cell Death Dis"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/kjm2.12684","article-title":"Dihydroartemisinin enhances gefitinib cytotoxicity against lung adenocarcinoma cells by inducing ROS-dependent apoptosis and ferroptosis","volume":"39","author":"XY","year":"2023","unstructured":"Lai XY, Shi YM and Zhou MM. Dihydroartemisinin enhances gefitinib cytotoxicity against lung adenocarcinoma cells by inducing ROS-dependent apoptosis and ferroptosis. Kaohsiung J Med Sci 2023; 39: 699-709.","journal-title":"Kaohsiung J Med Sci"},{"key":"ref178","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/1759-7714.13904","article-title":"Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy","volume":"12","author":"Tang","year":"2021","unstructured":"Tang X, Ding H, Liang M, Chen X, Yan Y, Wan N, Chen Q, Zhang J and Cao J. Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy. Thorac Cancer 2021; 12: 1219-1230.","journal-title":"Thorac Cancer"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3892\/or.2018.6188","article-title":"Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K\/Akt\/mTOR pathway","volume":"39","author":"Liu","year":"2018","unstructured":"Liu F, Gao S, Yang Y, Zhao X, Fan Y, Ma W, Yang D, Yang A and Yu Y. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K\/Akt\/mTOR pathway. Oncol Rep 2018; 39: 1523-1531.","journal-title":"Oncol Rep"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.3892\/etm.2017.5172","article-title":"Curcumin inhibits the development of non-small cell lung cancer by inhibiting autophagy and apoptosis","volume":"14","author":"Wang","year":"2017","unstructured":"Wang A, Wang J, Zhang S, Zhang H, Xu Z and Li X. Curcumin inhibits the development of non-small cell lung cancer by inhibiting autophagy and apoptosis. Exp Ther Med 2017; 14: 5075-5080.","journal-title":"Exp Ther Med"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/ddr.21298","article-title":"Baicalein induces caspase-dependent apoptosis associated with the generation of ROS and the activation of AMPK in human lung carcinoma A549 cells","volume":"77","author":"Kim","year":"2016","unstructured":"Kim HJ, Park C, Han MH, Hong SH, Kim GY, Hong SH, Kim ND and Choi YH. Baicalein induces caspase-dependent apoptosis associated with the generation of ROS and the activation of AMPK in human lung carcinoma A549 cells. Drug Dev Res 2016; 77: 73-86.","journal-title":"Drug Dev Res"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.7150\/ijbs.41768","article-title":"Drp1-mediated mitochondrial fission contributes to baicalein-induced apoptosis and autophagy in lung cancer via activation of AMPK signaling pathway","volume":"16","author":"Deng","year":"2020","unstructured":"Deng X, Liu J, Liu L, Sun X, Huang J and Dong J. Drp1-mediated mitochondrial fission contributes to baicalein-induced apoptosis and autophagy in lung cancer via activation of AMPK signaling pathway. Int J Biol Sci 2020; 16: 1403-1416.","journal-title":"Int J Biol Sci"},{"key":"ref183","doi-asserted-by":"publisher","first-page":"110965","DOI":"10.1016\/j.biopha.2020.110965","article-title":"Baicalein suppresses growth of non-small cell lung carcinoma by targeting MAP4K3","volume":"133","author":"Li","year":"2021","unstructured":"Li J, Yan L, Luo J, Tong L, Gao Y, Feng W, Wang F, Cui W, Li S and Sun Z. Baicalein suppresses growth of non-small cell lung carcinoma by targeting MAP4K3. Biomed Pharmacother 2021; 133: 110965.","journal-title":"Biomed Pharmacother"},{"key":"ref184","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1039\/C9FO02166C","article-title":"Ginsenoside Rk1 induces apoptosis and downregulates the expression of PD-L1 by targeting the NF-κB pathway in lung adenocarcinoma","volume":"11","author":"Hu","year":"2020","unstructured":"Hu M, Yang J, Qu L, Deng X, Duan Z, Fu R, Liang L and Fan D. Ginsenoside Rk1 induces apoptosis and downregulates the expression of PD-L1 by targeting the NF-κB pathway in lung adenocarcinoma. Food Funct 2020; 11: 456-471.","journal-title":"Food Funct"},{"key":"ref185","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2174\/1871520619666191209091230","article-title":"Ginsenoside Rh2 improves the cisplatin anti-tumor effect in lung adenocarcinoma A549 cells via superoxide and PD-L1","volume":"20","author":"Chen","year":"2020","unstructured":"Chen Y, Zhang Y, Song W, Zhang Y, Dong X and Tan M. Ginsenoside Rh2 improves the cisplatin anti-tumor effect in lung adenocarcinoma A549 cells via superoxide and PD-L1. Anticancer Agents Med Chem 2020; 20: 495-503.","journal-title":"Anticancer Agents Med Chem"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1139\/bcb-2018-0226","article-title":"Ginsenoside metabolite compound K induces apoptosis and autophagy in non-small cell lung cancer cells via AMPK-mTOR and JNK pathways","volume":"97","author":"Li","year":"2019","unstructured":"Li C, Dong Y, Wang L, Xu G, Yang Q, Tang X, Qiao Y and Cong Z. Ginsenoside metabolite compound K induces apoptosis and autophagy in non-small cell lung cancer cells via AMPK-mTOR and JNK pathways. Biochem Cell Biol 2019; 97: 406-414.","journal-title":"Biochem Cell Biol"},{"key":"ref187","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.biopha.2016.11.096","article-title":"Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell","volume":"85","author":"Xie","year":"2017","unstructured":"Xie Q, Wen H, Zhang Q, Zhou W, Lin X, Xie D and Liu Y. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell. Biomed Pharmacother 2017; 85: 16-21.","journal-title":"Biomed Pharmacother"},{"key":"ref188","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1172\/JCI129442","article-title":"Normal lung development needs self-eating","volume":"129","author":"Warburton","year":"2019","unstructured":"Warburton D and Bellusci S. Normal lung development needs self-eating. J Clin Invest 2019; 129: 2658-2659.","journal-title":"J Clin Invest"},{"key":"ref189","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1080\/21691401.2019.1648280","article-title":"Sirt1 modulates H3 phosphorylation and facilitates osteosarcoma cell autophagy","volume":"47","author":"Ying","year":"2019","unstructured":"Ying H, Ying B, Zhang J and Kong D. Sirt1 modulates H3 phosphorylation and facilitates osteosarcoma cell autophagy. Artif Cells Nanomed Biotechnol 2019; 47: 3374-3381.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref190","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1515\/biol-2020-0086","article-title":"LncRNA SNHG15 contributes to doxorubicin resistance of osteosarcoma cells through targeting the miR-381-3p\/GFRA1 axis","volume":"15","author":"Zhang","year":"2020","unstructured":"Zhang J, Rao D, Ma H, Kong D, Xu X and Lu H. LncRNA SNHG15 contributes to doxorubicin resistance of osteosarcoma cells through targeting the miR-381-3p\/GFRA1 axis. Open Life Sci 2020; 15: 871-883.","journal-title":"Open Life Sci"},{"key":"ref191","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1186\/s13018-023-04338-8","article-title":"Exosomal miR-331-3p derived from chemoresistant osteosarcoma cells induces chemoresistance through autophagy","volume":"18","author":"Meng","year":"2023","unstructured":"Meng C, Yang Y, Feng W, Ma P and Bai R. Exosomal miR-331-3p derived from chemoresistant osteosarcoma cells induces chemoresistance through autophagy. J Orthop Surg Res 2023; 18: 892.","journal-title":"J Orthop Surg Res"},{"key":"ref192","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00018-015-2104-y","article-title":"Autophagy inhibitors","volume":"73","author":"Pasquier","year":"2016","unstructured":"Pasquier B. Autophagy inhibitors. Cell Mol Life Sci 2016; 73: 985-1001.","journal-title":"Cell Mol Life Sci"},{"key":"ref193","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.apjtm.2015.07.024","article-title":"Effect of PI3K-mediated autophagy in human osteosarcoma MG63 cells on sensitivity to chemotherapy with cisplatin","volume":"8","author":"Miao","year":"2015","unstructured":"Miao XD, Cao L, Zhang Q, Hu XY and Zhang Y. Effect of PI3K-mediated autophagy in human osteosarcoma MG63 cells on sensitivity to chemotherapy with cisplatin. Asian Pac J Trop Med 2015; 8: 731-738.","journal-title":"Asian Pac J Trop Med"},{"key":"ref194","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2019.11.005","article-title":"At a glance: a history of autophagy and cancer","volume":"66","author":"Wen","year":"2020","unstructured":"Wen X and Klionsky DJ. At a glance: a history of autophagy and cancer. Semin Cancer Biol 2020; 66: 3-11.","journal-title":"Semin Cancer Biol"},{"key":"ref195","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.4161\/auto.32229","article-title":"A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors","volume":"10","author":"Akin","year":"2014","unstructured":"Akin D, Wang SK, Habibzadegah-Tari P, Law B, Ostrov D, Li M, Yin XM, Kim JS, Horenstein N and Dunn WA Jr. A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors. Autophagy 2014; 10: 2021-2035.","journal-title":"Autophagy"},{"key":"ref196","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3892\/ijo.2015.3227","article-title":"Apoptosis and antitumor effects induced by the combination of an mTOR inhibitor and an autophagy inhibitor in human osteosarcoma MG63 cells","volume":"48","author":"Horie","year":"2016","unstructured":"Horie R, Nakamura O, Yamagami Y, Mori M, Nishimura H, Fukuoka N and Yamamoto T. Apoptosis and antitumor effects induced by the combination of an mTOR inhibitor and an autophagy inhibitor in human osteosarcoma MG63 cells. Int J Oncol 2016; 48: 37-44.","journal-title":"Int J Oncol"},{"key":"ref197","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/15384101.2018.1467677","article-title":"Autophagy inhibition enhances celecoxib-induced apoptosis in osteosarcoma","volume":"17","author":"Zhou","year":"2018","unstructured":"Zhou P, Li Y, Li B, Zhang M, Xu C, Liu F, Bian L, Liu Y, Yao Y and Li D. Autophagy inhibition enhances celecoxib-induced apoptosis in osteosarcoma. Cell Cycle 2018; 17: 997-1006.","journal-title":"Cell Cycle"},{"key":"ref198","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12935-020-01720-y","article-title":"Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells","volume":"21","author":"Saini","year":"2021","unstructured":"Saini H, Sharma H, Mukherjee S, Chowdhury S and Chowdhury R. Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells. Cancer Cell Int 2021; 21: 52.","journal-title":"Cancer Cell Int"},{"key":"ref199","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3892\/ijo.2019.4902","article-title":"Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma","volume":"55","author":"Liao","year":"2019","unstructured":"Liao YX, Yu HY, Lv JY, Cai YR, Liu F, He ZM and He SS. Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma. Int J Oncol 2019; 55: 1213-1222.","journal-title":"Int J Oncol"},{"key":"ref200","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12967-016-0796-x","article-title":"c-Jun N-terminal kinase activation by nitrobenzoxadiazoles leads to late-stage autophagy inhibition","volume":"14","author":"Palumbo","year":"2016","unstructured":"Palumbo C, De Luca A, Rosato N, Forgione M, Rotili D and Caccuri AM. c-Jun N-terminal kinase activation by nitrobenzoxadiazoles leads to late-stage autophagy inhibition. J Transl Med 2016; 14: 37.","journal-title":"J Transl Med"},{"key":"ref201","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13046-018-0689-3","article-title":"SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition","volume":"37","author":"Wang","year":"2018","unstructured":"Wang W, Chen D and Zhu K. SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition. J Exp Clin Cancer Res 2018; 37: 37.","journal-title":"J Exp Clin Cancer Res"},{"key":"ref202","doi-asserted-by":"publisher","first-page":"8490","DOI":"10.1080\/21655979.2022.2051805","article-title":"Epigallocatechin-3-gallate suppresses the growth of human osteosarcoma by inhibiting the Wnt\/β-catenin signalling pathway","volume":"13","author":"Dong","year":"2022","unstructured":"Dong C, Wang Z, Shen P, Chen Y, Wang J and Wang H. Epigallocatechin-3-gallate suppresses the growth of human osteosarcoma by inhibiting the Wnt\/β-catenin signalling pathway. Bioengineered 2022; 13: 8490-8502.","journal-title":"Bioengineered"},{"key":"ref203","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tips.2014.11.004","article-title":"Current treatment strategies for inhibiting mTOR in cancer","volume":"36","author":"Chiarini","year":"2015","unstructured":"Chiarini F, Evangelisti C, McCubrey JA and Martelli AM. Current treatment strategies for inhibiting mTOR in cancer. Trends Pharmacol Sci 2015; 36: 124-135.","journal-title":"Trends Pharmacol Sci"},{"key":"ref204","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.3390\/ijms22115804","article-title":"Autophagy modulators in cancer therapy","volume":"22","author":"Buzun","year":"2021","unstructured":"Buzun K, Gornowicz A, Lesyk R, Bielawski K and Bielawska A. Autophagy modulators in cancer therapy. Int J Mol Sci 2021; 22: 5804.","journal-title":"Int J Mol Sci"},{"key":"ref205","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/kjm2.12361","article-title":"Autophagy modulation as a potential targeted cancer therapy: from drug repurposing to new drug development","volume":"37","author":"CJ","year":"2021","unstructured":"Lin CJ, Tsao YN and Shu CW. Autophagy modulation as a potential targeted cancer therapy: from drug repurposing to new drug development. Kaohsiung J Med Sci 2021; 37: 166-171.","journal-title":"Kaohsiung J Med Sci"},{"key":"ref206","doi-asserted-by":"publisher","first-page":"659181","DOI":"10.3389\/fonc.2021.659181","article-title":"PF-06409577 activates AMPK signaling and inhibits osteosarcoma cell growth","volume":"11","author":"Zhu","year":"2021","unstructured":"Zhu YR, Zhang XY, Wu QP, Yu CJ, Liu YY and Zhang YQ. PF-06409577 activates AMPK signaling and inhibits osteosarcoma cell growth. Front Oncol 2021; 11: 659181.","journal-title":"Front Oncol"},{"key":"ref207","unstructured":"Du Y, Zhang J, Yan S, Tao Z, Wang C, Huang M and Zhang X. Oridonin inhibits the proliferation, migration and invasion of human osteosarcoma cells via suppression of matrix metalloproteinase expression and STAT3 signalling pathway. J BUON 2019; 24: 1175-1180."},{"key":"ref208","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41419-017-0031-6","article-title":"Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway","volume":"9","author":"Lu","year":"2018","unstructured":"Lu Y, Sun Y, Zhu J, Yu L, Jiang X, Zhang J, Dong X, Ma B and Zhang Q. Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway. Cell Death Dis 2018; 9: 15.","journal-title":"Cell Death Dis"},{"key":"ref209","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4161\/cbt.6.2.3621","article-title":"Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells","volume":"6","author":"Jin","year":"2007","unstructured":"Jin S, Shen JN, Wang J, Huang G and Zhou JG. Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells. Cancer Biol Ther 2007; 6: 261-268.","journal-title":"Cancer Biol Ther"},{"key":"ref210","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.phymed.2012.10.016","article-title":"Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis","volume":"20","author":"Kimura","year":"2013","unstructured":"Kimura Y and Sumiyoshi M. Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis. Phytomedicine 2013; 20: 328-336.","journal-title":"Phytomedicine"},{"key":"ref211","unstructured":"Lin CC, Kuo CL, Lee MH, Lai KC, Lin JP, Yang JS, Yu CS, Lu CC, Chiang JH, Chueh FS and Chung JG. Wogonin triggers apoptosis in human osteosarcoma U-2 OS cells through the endoplasmic reticulum stress, mitochondrial dysfunction and caspase-3-dependent signaling pathways. Int J Oncol 2011; 39: 217-224."},{"key":"ref212","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.21873\/invivo.11878","article-title":"Wogonin influences osteosarcoma stem cell stemness through ROS-dependent signaling","volume":"34","author":"Koh","year":"2020","unstructured":"Koh H, Sun HN, Xing Z, Liu R, Chandimali N, Kwon T and Lee DS. Wogonin influences osteosarcoma stem cell stemness through ROS-dependent signaling. In Vivo 2020; 34: 1077-1084.","journal-title":"In Vivo"},{"key":"ref213","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/nu13020354","article-title":"Assessment of the nutraceutical effects of oleuropein and the cytotoxic effects of adriamycin, when administered alone and in combination, in MG-63 human osteosarcoma cells","volume":"13","author":"Gioti","year":"2021","unstructured":"Gioti K, Papachristodoulou A, Benaki D, Aligiannis N, Skaltsounis AL, Mikros E and Tenta R. Assessment of the nutraceutical effects of oleuropein and the cytotoxic effects of adriamycin, when administered alone and in combination, in MG-63 human osteosarcoma cells. Nutrients 2021; 13: 354.","journal-title":"Nutrients"},{"key":"ref214","doi-asserted-by":"publisher","unstructured":"Morana JM, Leal-Hernande O, Canal-Macías ML, Roncero-Martin R, Guerrero-Bonmatty R, Aliaga I and Zamorano JD. Antiproliferative properties of oleuropein in human osteosarcoma cells. Nat Prod Commun 2016; 11: 491-492.","DOI":"10.1177\/1934578X1601100418"},{"key":"ref215","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.21873\/anticanres.13234","article-title":"Anticancer potential of oleuropein, the polyphenol of olive oil, with 2-methoxyestradiol, separately or in combination, in human osteosarcoma cells","volume":"39","author":"Przychodzen","year":"2019","unstructured":"Przychodzen P, Wyszkowska R, Gorzynik-Debicka M, Kostrzewa T, Kuban-Jankowska A and Gorska-Ponikowska M. Anticancer potential of oleuropein, the polyphenol of olive oil, with 2-methoxyestradiol, separately or in combination, in human osteosarcoma cells. Anticancer Res 2019; 39: 1243-1251.","journal-title":"Anticancer Res"},{"key":"ref216","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.2147\/CMAR.S238093","article-title":"Evodiamine exerts anticancer effects against 143B and MG63 cells through the Wnt\/β-catenin signaling pathway","volume":"12","author":"Yang","year":"2020","unstructured":"Yang S, Chen J, Tan T, Wang N, Huang Y, Wang Y, Yuan X, Zhang P, Luo J and Luo X. Evodiamine exerts anticancer effects against 143B and MG63 cells through the Wnt\/β-catenin signaling pathway. Cancer Manag Res 2020; 12: 2875-2888.","journal-title":"Cancer Manag Res"},{"key":"ref217","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3892\/ol.2014.2791","article-title":"Inhibitory effects of evodiamine on human osteosarcoma cell proliferation and apoptosis","volume":"9","author":"Bai","year":"2015","unstructured":"Bai X, Meng H, Ma L and Guo A. Inhibitory effects of evodiamine on human osteosarcoma cell proliferation and apoptosis. Oncol Lett 2015; 9: 801-805.","journal-title":"Oncol Lett"},{"key":"ref218","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3892\/or.2015.4084","article-title":"Evodiamine inhibits the proliferation of human osteosarcoma cells by blocking PI3K\/Akt signaling","volume":"34","author":"Meng","year":"2015","unstructured":"Meng ZJ, Wu N, Liu Y, Shu KJ, Zou X, Zhang RX, Pi CJ, He BC, Ke ZY, Chen L, Deng ZL and Yin LJ. Evodiamine inhibits the proliferation of human osteosarcoma cells by blocking PI3K\/Akt signaling. Oncol Rep 2015; 34: 1388-1396.","journal-title":"Oncol Rep"},{"key":"ref219","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1158\/1078-0432.CCR-06-1559","article-title":"Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells","volume":"13","author":"Kishida","year":"2007","unstructured":"Kishida Y, Yoshikawa H and Myoui A. Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells. Clin Cancer Res 2007; 13: 59-67.","journal-title":"Clin Cancer Res"},{"key":"ref220","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000452532","article-title":"Parthenolide induces reactive oxygen species-mediated autophagic cell death in human osteosarcoma cells","volume":"40","author":"Yang","year":"2016","unstructured":"Yang C, Yang QO, Kong QJ, Yuan W and Ou Yang YP. Parthenolide induces reactive oxygen species-mediated autophagic cell death in human osteosarcoma cells. Cell Physiol Biochem 2016; 40: 146-154.","journal-title":"Cell Physiol Biochem"},{"key":"ref221","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/jcp.24131","article-title":"Parthenolide induces caspase-independent and AIF-mediated cell death in human osteosarcoma and melanoma cells","volume":"228","author":"D&#x2019","year":"2013","unstructured":"D’Anneo A, Carlisi D, Lauricella M, Emanuele S, Di Fiore R, Vento R and Tesoriere G. Parthenolide induces caspase-independent and AIF-mediated cell death in human osteosarcoma and melanoma cells. J Cell Physiol 2013; 228: 952-967.","journal-title":"J Cell Physiol"},{"key":"ref222","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1248\/bpb.33.816","article-title":"Shikonin induces apoptosis through reactive oxygen species\/extracellular signal-regulated kinase pathway in osteosarcoma cells","volume":"33","author":"Chang","year":"2010","unstructured":"Chang IC, Huang YJ, Chiang TI, Yeh CW and Hsu LS. Shikonin induces apoptosis through reactive oxygen species\/extracellular signal-regulated kinase pathway in osteosarcoma cells. Biol Pharm Bull 2010; 33: 816-824.","journal-title":"Biol Pharm Bull"},{"key":"ref223","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3892\/mmr.2017.6729","article-title":"Shikonin promotes adriamycininduced apoptosis by upregulating caspase3 and caspase8 in osteosarcoma","volume":"16","author":"Yang","year":"2017","unstructured":"Yang Q, Li S, Fu Z, Lin B, Zhou Z, Wang Z, Hua Y and Cai Z. Shikonin promotes adriamycininduced apoptosis by upregulating caspase3 and caspase8 in osteosarcoma. Mol Med Rep 2017; 16: 1347-1352.","journal-title":"Mol Med Rep"},{"key":"ref224","doi-asserted-by":"publisher","first-page":"8499","DOI":"10.1007\/s11033-020-05892-8","article-title":"Berberine reverses epithelial-mesenchymal transition and modulates histone methylation in osteosarcoma cells","volume":"47","author":"Mishra","year":"2020","unstructured":"Mishra R, Nathani S, Varshney R, Sircar D and Roy P. Berberine reverses epithelial-mesenchymal transition and modulates histone methylation in osteosarcoma cells. Mol Biol Rep 2020; 47: 8499-8511.","journal-title":"Mol Biol Rep"},{"key":"ref225","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mrfmmm.2008.12.009","article-title":"Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage","volume":"662","author":"Liu","year":"2009","unstructured":"Liu Z, Liu Q, Xu B, Wu J, Guo C, Zhu F, Yang Q, Gao G, Gong Y and Shao C. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. Mutat Res 2009; 662: 75-83.","journal-title":"Mutat Res"},{"key":"ref226","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.3390\/molecules26061666","article-title":"Berberine and cisplatin exhibit synergistic anticancer effects on osteosarcoma MG-63 cells by inhibiting the MAPK pathway","volume":"26","author":"Gao","year":"2021","unstructured":"Gao X, Zhang C, Wang Y, Zhang P, Zhang J and Hong T. Berberine and cisplatin exhibit synergistic anticancer effects on osteosarcoma MG-63 cells by inhibiting the MAPK pathway. Molecules 2021; 26: 1666.","journal-title":"Molecules"},{"key":"ref227","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3892\/or.2016.4957","article-title":"Triptolide induces the cell apoptosis of osteosarcoma cells through the TRAIL pathway","volume":"36","author":"Zhao","year":"2016","unstructured":"Zhao X, Zhang Q and Chen L. Triptolide induces the cell apoptosis of osteosarcoma cells through the TRAIL pathway. Oncol Rep 2016; 36: 1499-1505.","journal-title":"Oncol Rep"},{"key":"ref228","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.bbrc.2018.01.052","article-title":"Anti-tumor effects of triptolide on angiogenesis and cell apoptosis in osteosarcoma cells by inducing autophagy via repressing Wnt\/β-Catenin signaling","volume":"496","author":"Li","year":"2018","unstructured":"Li X, Lu Q, Xie W, Wang Y and Wang G. Anti-tumor effects of triptolide on angiogenesis and cell apoptosis in osteosarcoma cells by inducing autophagy via repressing Wnt\/β-Catenin signaling. Biochem Biophys Res Commun 2018; 496: 443-449.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref229","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4149\/neo_2018_170109N16","article-title":"Triptolide induces mitochondrial apoptosis through modulating dual specificity phosphatase 1\/mitogen-activated protein kinases cascade in osteosarcoma cells","volume":"65","author":"Qin","year":"2018","unstructured":"Qin W, Li S, Miao Y, Shi Q, Wang Y, Li J, Chen Z, Wang J and Ling C. Triptolide induces mitochondrial apoptosis through modulating dual specificity phosphatase 1\/mitogen-activated protein kinases cascade in osteosarcoma cells. Neoplasma 2018; 65: 21-33.","journal-title":"Neoplasma"},{"key":"ref230","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3892\/etm.2017.4134","article-title":"Antitumor effect of sunitinib in human prostate cancer cells functions via autophagy","volume":"13","author":"Wang","year":"2017","unstructured":"Wang B, Lu D, Xuan M and Hu W. Antitumor effect of sunitinib in human prostate cancer cells functions via autophagy. Exp Ther Med 2017; 13: 1285-1294.","journal-title":"Exp Ther Med"}],"container-title":["American Journal of Clinical and Experimental Urology"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajceu\/13\/2\/ajceu0164154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:55:25Z","timestamp":1766022925000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajceu\/13\/2\/ajceu0164154.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":231,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/qcpv6064","relation":{},"ISSN":["2330-1910"],"issn-type":[{"value":"2330-1910","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}